0001160958
INPHI CORP
false
--12-31
Q3
2020
74,326
139,448
0.001
0.001
10,000,000
10,000,000
0
0
0.001
0.001
500,000,000
500,000,000
52,062,081
52,062,081
45,909,466
45,909,466
0
5
5
0
1
10
5
110
0
0
0
21
21
0
0
0
0
4
4
0
2
3
1
0
0
25,000
00011609582020-01-012020-09-30
xbrli:shares
00011609582020-11-03
iso4217:USD
00011609582020-09-30
00011609582019-12-31
iso4217:USDxbrli:shares
00011609582020-07-012020-09-30
00011609582019-07-012019-09-30
00011609582019-01-012019-09-30
0001160958us-gaap:CommonStockMember2019-12-31
0001160958us-gaap:AdditionalPaidInCapitalMember2019-12-31
0001160958us-gaap:RetainedEarningsMember2019-12-31
0001160958us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-12-31
0001160958us-gaap:CommonStockMember2020-01-012020-03-31
0001160958us-gaap:AdditionalPaidInCapitalMember2020-01-012020-03-31
0001160958us-gaap:RetainedEarningsMember2020-01-012020-03-31
0001160958us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-01-012020-03-31
00011609582020-01-012020-03-31
0001160958us-gaap:CommonStockMember2020-03-31
0001160958us-gaap:AdditionalPaidInCapitalMember2020-03-31
0001160958us-gaap:RetainedEarningsMember2020-03-31
0001160958us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-03-31
00011609582020-03-31
0001160958us-gaap:CommonStockMember2020-04-012020-06-30
0001160958us-gaap:AdditionalPaidInCapitalMember2020-04-012020-06-30
0001160958us-gaap:RetainedEarningsMember2020-04-012020-06-30
0001160958us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-04-012020-06-30
00011609582020-04-012020-06-30
0001160958us-gaap:CommonStockMember2020-06-30
0001160958us-gaap:AdditionalPaidInCapitalMember2020-06-30
0001160958us-gaap:RetainedEarningsMember2020-06-30
0001160958us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-06-30
00011609582020-06-30
0001160958us-gaap:CommonStockMember2020-07-012020-09-30
0001160958us-gaap:AdditionalPaidInCapitalMember2020-07-012020-09-30
0001160958us-gaap:RetainedEarningsMember2020-07-012020-09-30
0001160958us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-07-012020-09-30
0001160958us-gaap:CommonStockMember2020-09-30
0001160958us-gaap:AdditionalPaidInCapitalMember2020-09-30
0001160958us-gaap:RetainedEarningsMember2020-09-30
0001160958us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-09-30
0001160958us-gaap:CommonStockMember2018-12-31
0001160958us-gaap:AdditionalPaidInCapitalMember2018-12-31
0001160958us-gaap:RetainedEarningsMember2018-12-31
0001160958us-gaap:AccumulatedOtherComprehensiveIncomeMember2018-12-31
00011609582018-12-31
0001160958us-gaap:CommonStockMember2019-01-012019-03-31
0001160958us-gaap:AdditionalPaidInCapitalMember2019-01-012019-03-31
0001160958us-gaap:RetainedEarningsMember2019-01-012019-03-31
0001160958us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-01-012019-03-31
00011609582019-01-012019-03-31
0001160958us-gaap:CommonStockMember2019-03-31
0001160958us-gaap:AdditionalPaidInCapitalMember2019-03-31
0001160958us-gaap:RetainedEarningsMember2019-03-31
0001160958us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-03-31
00011609582019-03-31
0001160958us-gaap:CommonStockMember2019-04-012019-06-30
0001160958us-gaap:AdditionalPaidInCapitalMember2019-04-012019-06-30
0001160958us-gaap:RetainedEarningsMember2019-04-012019-06-30
0001160958us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-04-012019-06-30
00011609582019-04-012019-06-30
0001160958us-gaap:CommonStockMember2019-06-30
0001160958us-gaap:AdditionalPaidInCapitalMember2019-06-30
0001160958us-gaap:RetainedEarningsMember2019-06-30
0001160958us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-06-30
00011609582019-06-30
0001160958us-gaap:CommonStockMember2019-07-012019-09-30
0001160958us-gaap:AdditionalPaidInCapitalMember2019-07-012019-09-30
0001160958us-gaap:RetainedEarningsMember2019-07-012019-09-30
0001160958us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-07-012019-09-30
0001160958us-gaap:CommonStockMember2019-09-30
0001160958us-gaap:AdditionalPaidInCapitalMember2019-09-30
0001160958us-gaap:RetainedEarningsMember2019-09-30
0001160958us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-09-30
00011609582019-09-30
0001160958iphi:EsiliconMember2020-01-012020-09-30
0001160958iphi:EsiliconMember2019-01-012019-09-30
0001160958iphi:EsiliconMember2020-01-102020-01-10
0001160958iphi:ArriveMember2020-05-182020-05-18
0001160958iphi:RevisionMember2019-01-012019-09-30
0001160958srt:ScenarioPreviouslyReportedMember2019-01-012019-09-30
0001160958iphi:EsiliconMember2020-01-10
0001160958iphi:EsiliconMemberus-gaap:ContractualRightsMember2020-01-10
utr:Y
0001160958iphi:EsiliconMemberus-gaap:ContractualRightsMember2020-01-102020-01-10
0001160958iphi:EsiliconMemberus-gaap:DevelopedTechnologyRightsMember2020-01-10
0001160958iphi:EsiliconMemberus-gaap:DevelopedTechnologyRightsMember2020-01-102020-01-10
0001160958iphi:EsiliconMemberus-gaap:ComputerSoftwareIntangibleAssetMember2020-01-10
0001160958iphi:EsiliconMemberus-gaap:ComputerSoftwareIntangibleAssetMembersrt:MinimumMember2020-01-102020-01-10
0001160958iphi:EsiliconMemberus-gaap:ComputerSoftwareIntangibleAssetMembersrt:MaximumMember2020-01-102020-01-10
0001160958iphi:EsiliconMember2019-01-012020-09-30
0001160958iphi:EsiliconMember2019-01-012019-12-31
0001160958iphi:EsiliconMemberus-gaap:GeneralAndAdministrativeExpenseMember2020-01-012020-09-30
0001160958iphi:EsiliconMember2020-07-012020-09-30
0001160958iphi:EsiliconMember2020-01-112020-09-30
0001160958iphi:EsiliconMember2020-01-102020-09-30
0001160958iphi:ArriveMember2020-05-18
0001160958iphi:ArriveMemberus-gaap:DevelopedTechnologyRightsMember2020-05-18
0001160958iphi:ArriveMemberus-gaap:DevelopedTechnologyRightsMember2020-05-182020-05-18
0001160958iphi:ArriveMemberus-gaap:GeneralAndAdministrativeExpenseMember2020-01-012020-09-30
0001160958iphi:ArriveMember2020-07-012020-09-30
0001160958iphi:ArriveMember2020-05-192020-09-30
0001160958iphi:ESiliconAndArriveMember2020-07-012020-09-30
0001160958iphi:ESiliconAndArriveMember2019-07-012019-09-30
0001160958iphi:ESiliconAndArriveMember2020-01-012020-09-30
0001160958iphi:ESiliconAndArriveMember2019-01-012019-09-30
0001160958us-gaap:USTreasurySecuritiesMember2020-09-30
0001160958us-gaap:USTreasurySecuritiesMember2019-12-31
0001160958us-gaap:USStatesAndPoliticalSubdivisionsMember2020-09-30
0001160958us-gaap:USStatesAndPoliticalSubdivisionsMember2019-12-31
0001160958us-gaap:CorporateDebtSecuritiesMember2020-09-30
0001160958us-gaap:CorporateDebtSecuritiesMember2019-12-31
0001160958us-gaap:AssetBackedSecuritiesMember2020-09-30
0001160958us-gaap:AssetBackedSecuritiesMember2019-12-31
0001160958us-gaap:CommercialPaperMember2020-09-30
0001160958us-gaap:CommercialPaperMember2019-12-31
0001160958us-gaap:CertificatesOfDepositMember2020-09-30
0001160958us-gaap:CertificatesOfDepositMember2019-12-31
xbrli:pure
0001160958country:TW2020-09-30
0001160958country:TW2020-01-012020-09-30
0001160958country:TW2019-12-31
0001160958country:TW2019-01-012019-12-31
0001160958us-gaap:OtherNoncurrentAssetsMemberiphi:EquitySecuritiesFairValueBasedOnObservableTransactionMember2020-09-30
0001160958iphi:EquitySecuritiesFairValueBasedOnObservableTransactionMemberus-gaap:OtherIncomeMember2020-01-012020-09-30
0001160958us-gaap:EquipmentMember2020-09-30
0001160958us-gaap:EquipmentMember2019-12-31
0001160958iphi:OfficeSoftwareAndComputerEquipmentMember2020-09-30
0001160958iphi:OfficeSoftwareAndComputerEquipmentMember2019-12-31
0001160958us-gaap:FurnitureAndFixturesMember2020-09-30
0001160958us-gaap:FurnitureAndFixturesMember2019-12-31
0001160958us-gaap:LeaseholdImprovementsMember2020-09-30
0001160958us-gaap:LeaseholdImprovementsMember2019-12-31
00011609582019-01-012019-12-31
0001160958us-gaap:DevelopedTechnologyRightsMember2020-09-30
0001160958us-gaap:DevelopedTechnologyRightsMember2019-12-31
0001160958us-gaap:CustomerRelationshipsMember2020-09-30
0001160958us-gaap:CustomerRelationshipsMember2019-12-31
0001160958us-gaap:ContractualRightsMember2020-09-30
0001160958us-gaap:ContractualRightsMember2019-12-31
0001160958us-gaap:TradeNamesMember2020-09-30
0001160958us-gaap:TradeNamesMember2019-12-31
0001160958us-gaap:PatentsMember2020-09-30
0001160958us-gaap:PatentsMember2019-12-31
0001160958us-gaap:ComputerSoftwareIntangibleAssetMember2020-09-30
0001160958us-gaap:ComputerSoftwareIntangibleAssetMember2019-12-31
0001160958us-gaap:CostOfSalesMember2020-07-012020-09-30
0001160958us-gaap:CostOfSalesMember2019-07-012019-09-30
0001160958us-gaap:CostOfSalesMember2020-01-012020-09-30
0001160958us-gaap:CostOfSalesMember2019-01-012019-09-30
0001160958us-gaap:ResearchAndDevelopmentExpenseMember2020-07-012020-09-30
0001160958us-gaap:ResearchAndDevelopmentExpenseMember2019-07-012019-09-30
0001160958us-gaap:ResearchAndDevelopmentExpenseMember2020-01-012020-09-30
0001160958us-gaap:ResearchAndDevelopmentExpenseMember2019-01-012019-09-30
0001160958us-gaap:SellingAndMarketingExpenseMember2020-07-012020-09-30
0001160958us-gaap:SellingAndMarketingExpenseMember2019-07-012019-09-30
0001160958us-gaap:SellingAndMarketingExpenseMember2020-01-012020-09-30
0001160958us-gaap:SellingAndMarketingExpenseMember2019-01-012019-09-30
0001160958us-gaap:GeneralAndAdministrativeExpenseMember2020-07-012020-09-30
0001160958us-gaap:GeneralAndAdministrativeExpenseMember2019-07-012019-09-30
0001160958us-gaap:GeneralAndAdministrativeExpenseMember2020-01-012020-09-30
0001160958us-gaap:GeneralAndAdministrativeExpenseMember2019-01-012019-09-30
0001160958us-gaap:DevelopedTechnologyRightsMember2020-01-012020-09-30
0001160958us-gaap:CustomerRelationshipsMember2020-01-012020-09-30
0001160958us-gaap:ContractualRightsMember2020-01-012020-09-30
0001160958us-gaap:TradeNamesMember2020-01-012020-09-30
0001160958us-gaap:PatentsMember2020-01-012020-09-30
0001160958us-gaap:ComputerSoftwareIntangibleAssetMember2020-01-012020-09-30
0001160958srt:MinimumMember2020-09-30
0001160958srt:MaximumMember2020-09-30
0001160958iphi:LiabilitiesMember2020-09-30
0001160958iphi:ConvertibleNotes2015Memberus-gaap:ConvertibleDebtMember2015-12-31
0001160958iphi:ConvertibleNotes2015Memberus-gaap:ConvertibleDebtMember2015-01-012015-12-31
0001160958iphi:ConvertibleNotes2015Memberus-gaap:ConvertibleDebtMember2020-07-012020-09-30
0001160958iphi:ConvertibleNotes2015Memberus-gaap:ConvertibleDebtMember2019-07-012019-09-30
0001160958iphi:ConvertibleNotes2015Memberus-gaap:ConvertibleDebtMember2020-01-012020-09-30
0001160958iphi:ConvertibleNotes2015Memberus-gaap:ConvertibleDebtMember2019-01-012019-09-30
iso4217:USDthunderdome:item
0001160958iphi:ConvertibleNotes2016Memberus-gaap:ConvertibleDebtMember2016-09-30
0001160958iphi:ConvertibleNotes2016Memberus-gaap:ConvertibleDebtMember2016-09-012016-09-30
0001160958iphi:ConvertibleNotes2016Memberus-gaap:ConvertibleDebtMember2020-07-012020-09-30
0001160958iphi:ConvertibleNotes2016Memberus-gaap:ConvertibleDebtMember2019-07-012019-09-30
0001160958iphi:ConvertibleNotes2016Memberus-gaap:ConvertibleDebtMember2020-01-012020-09-30
0001160958iphi:ConvertibleNotes2016Memberus-gaap:ConvertibleDebtMember2019-01-012019-09-30
0001160958iphi:ConvertibleNotes2020Memberus-gaap:ConvertibleDebtMember2020-04-24
0001160958iphi:ConvertibleNotes2020Memberus-gaap:ConvertibleDebtMember2020-04-242020-04-24
0001160958iphi:ConversionCircumstance1Memberiphi:ConvertibleNotes2020Memberus-gaap:ConvertibleDebtMember2020-04-242020-04-24
0001160958iphi:ConvertibleNotes2020Memberus-gaap:ConvertibleDebtMember2020-07-012020-09-30
0001160958iphi:ConvertibleNotes2020Memberus-gaap:ConvertibleDebtMember2020-01-012020-09-30
0001160958iphi:ExchangeForConvertibleNotes2015Member2020-04-012020-06-30
0001160958iphi:ExchangeForConvertibleNotes2016Member2020-04-012020-06-30
0001160958iphi:ExchangeForConvertibleNotes2016Member2020-07-012020-09-30
0001160958us-gaap:ConvertibleDebtMember2020-04-242020-04-24
0001160958iphi:ConvertibleNotes2015Memberus-gaap:ConvertibleDebtMember2020-04-242020-04-24
0001160958iphi:ConvertibleNotes2016Memberus-gaap:ConvertibleDebtMember2020-04-242020-04-24
0001160958iphi:ConvertibleNotes2016IssuanceCostsMemberus-gaap:ConvertibleDebtMember2020-04-242020-04-24
0001160958iphi:ConvertibleNotes2016IssuanceCostsMemberus-gaap:ConvertibleDebtMember2020-09-30
0001160958us-gaap:OtherCurrentLiabilitiesMember2020-09-30
0001160958us-gaap:OtherCurrentLiabilitiesMember2019-12-31
0001160958us-gaap:OtherNoncurrentLiabilitiesMember2020-09-30
0001160958us-gaap:OtherNoncurrentLiabilitiesMember2019-12-31
0001160958us-gaap:EmployeeStockOptionMember2020-07-012020-09-30
0001160958us-gaap:EmployeeStockOptionMember2019-07-012019-09-30
0001160958us-gaap:EmployeeStockOptionMember2020-01-012020-09-30
0001160958us-gaap:EmployeeStockOptionMember2019-01-012019-09-30
0001160958iphi:RestrictedStockAndMarketValueStockUnitsMember2020-07-012020-09-30
0001160958iphi:RestrictedStockAndMarketValueStockUnitsMember2019-07-012019-09-30
0001160958iphi:RestrictedStockAndMarketValueStockUnitsMember2020-01-012020-09-30
0001160958iphi:RestrictedStockAndMarketValueStockUnitsMember2019-01-012019-09-30
0001160958us-gaap:ConvertibleDebtSecuritiesMember2020-07-012020-09-30
0001160958us-gaap:ConvertibleDebtSecuritiesMember2019-07-012019-09-30
0001160958us-gaap:ConvertibleDebtSecuritiesMember2020-01-012020-09-30
0001160958us-gaap:ConvertibleDebtSecuritiesMember2019-01-012019-09-30
0001160958us-gaap:RestrictedStockUnitsRSUMember2020-01-012020-09-30
0001160958us-gaap:RestrictedStockUnitsRSUMember2019-12-31
0001160958us-gaap:RestrictedStockUnitsRSUMember2020-09-30
0001160958us-gaap:PerformanceSharesMember2020-01-012020-09-30
0001160958us-gaap:PerformanceSharesMember2020-09-30
0001160958iphi:MarketValueStockUnitsMember2020-02-012020-02-28
0001160958iphi:MarketValueStockUnitsMembersrt:MinimumMember2020-02-012020-02-28
0001160958iphi:MarketValueStockUnitsMembersrt:MaximumMember2020-02-012020-02-28
0001160958iphi:TwoYearTermMarketValueStockUnitsMember2020-01-012020-09-30
0001160958iphi:ThreeYearTermMarketValueStockUnitsMember2020-01-012020-09-30
0001160958iphi:EmployeeStockPurchasePlanMember2011-12-012011-12-31
0001160958iphi:EmployeeStockPurchasePlanMember2020-01-012020-09-30
0001160958iphi:EmployeeStockPurchasePlanMember2020-07-012020-09-30
0001160958iphi:EmployeeStockPurchasePlanMember2019-07-012019-09-30
0001160958iphi:EmployeeStockPurchasePlanMember2019-01-012019-09-30
0001160958us-gaap:MoneyMarketFundsMember2020-09-30
0001160958us-gaap:FairValueInputsLevel1Memberus-gaap:MoneyMarketFundsMember2020-09-30
0001160958us-gaap:FairValueInputsLevel2Memberus-gaap:MoneyMarketFundsMember2020-09-30
0001160958us-gaap:FairValueInputsLevel1Memberus-gaap:CommercialPaperMember2020-09-30
0001160958us-gaap:FairValueInputsLevel2Memberus-gaap:CommercialPaperMember2020-09-30
0001160958us-gaap:MunicipalBondsMember2020-09-30
0001160958us-gaap:FairValueInputsLevel1Memberus-gaap:MunicipalBondsMember2020-09-30
0001160958us-gaap:FairValueInputsLevel2Memberus-gaap:MunicipalBondsMember2020-09-30
0001160958us-gaap:FairValueInputsLevel1Memberus-gaap:CorporateDebtSecuritiesMember2020-09-30
0001160958us-gaap:FairValueInputsLevel2Memberus-gaap:CorporateDebtSecuritiesMember2020-09-30
0001160958us-gaap:FairValueInputsLevel1Memberus-gaap:AssetBackedSecuritiesMember2020-09-30
0001160958us-gaap:FairValueInputsLevel2Memberus-gaap:AssetBackedSecuritiesMember2020-09-30
0001160958us-gaap:FairValueInputsLevel1Member2020-09-30
0001160958us-gaap:FairValueInputsLevel2Member2020-09-30
0001160958us-gaap:MoneyMarketFundsMember2019-12-31
0001160958us-gaap:FairValueInputsLevel1Memberus-gaap:MoneyMarketFundsMember2019-12-31
0001160958us-gaap:FairValueInputsLevel2Memberus-gaap:MoneyMarketFundsMember2019-12-31
0001160958us-gaap:FairValueInputsLevel1Memberus-gaap:CommercialPaperMember2019-12-31
0001160958us-gaap:FairValueInputsLevel2Memberus-gaap:CommercialPaperMember2019-12-31
0001160958us-gaap:MunicipalBondsMember2019-12-31
0001160958us-gaap:FairValueInputsLevel1Memberus-gaap:MunicipalBondsMember2019-12-31
0001160958us-gaap:FairValueInputsLevel2Memberus-gaap:MunicipalBondsMember2019-12-31
0001160958us-gaap:FairValueInputsLevel1Memberus-gaap:USTreasurySecuritiesMember2019-12-31
0001160958us-gaap:FairValueInputsLevel2Memberus-gaap:USTreasurySecuritiesMember2019-12-31
0001160958us-gaap:FairValueInputsLevel1Memberus-gaap:CorporateDebtSecuritiesMember2019-12-31
0001160958us-gaap:FairValueInputsLevel2Memberus-gaap:CorporateDebtSecuritiesMember2019-12-31
0001160958us-gaap:FairValueInputsLevel1Memberus-gaap:AssetBackedSecuritiesMember2019-12-31
0001160958us-gaap:FairValueInputsLevel2Memberus-gaap:AssetBackedSecuritiesMember2019-12-31
0001160958us-gaap:FairValueInputsLevel1Memberus-gaap:CertificatesOfDepositMember2019-12-31
0001160958us-gaap:FairValueInputsLevel2Memberus-gaap:CertificatesOfDepositMember2019-12-31
0001160958us-gaap:FairValueInputsLevel1Member2019-12-31
0001160958us-gaap:FairValueInputsLevel2Member2019-12-31
0001160958country:CN2020-07-012020-09-30
0001160958country:CN2019-07-012019-09-30
0001160958country:CN2020-01-012020-09-30
0001160958country:CN2019-01-012019-09-30
0001160958country:US2020-07-012020-09-30
0001160958country:US2019-07-012019-09-30
0001160958country:US2020-01-012020-09-30
0001160958country:US2019-01-012019-09-30
0001160958country:TH2020-07-012020-09-30
0001160958country:TH2019-07-012019-09-30
0001160958country:TH2020-01-012020-09-30
0001160958country:TH2019-01-012019-09-30
0001160958iphi:OtherCountryMember2020-07-012020-09-30
0001160958iphi:OtherCountryMember2019-07-012019-09-30
0001160958iphi:OtherCountryMember2020-01-012020-09-30
0001160958iphi:OtherCountryMember2019-01-012019-09-30
0001160958us-gaap:NonUsMember2020-09-30
0001160958us-gaap:NonUsMember2019-12-31
0001160958us-gaap:IndemnificationGuaranteeMember2020-09-30
0001160958us-gaap:IndemnificationGuaranteeMember2019-12-31
0001160958iphi:MarvellTechnologyGroupLtdMemberus-gaap:SubsequentEventMember2020-10-29
0001160958us-gaap:SubsequentEventMember2020-10-29
0001160958iphi:MarvellTechnologyGroupLtdMemberus-gaap:SubsequentEventMember2020-10-292020-10-29
0001160958iphi:MarvellTechnologyGroupLtdMemberus-gaap:SubsequentEventMember2020-10-292020-10-29
0001160958us-gaap:ConvertibleDebtMember2020-01-012020-09-30
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
Notes to Unaudited Condensed Consolidated Financial Statements
(Dollars in thousands except share and per share amounts)
1. Organization and Basis of Presentation
Inphi Corporation (the “Company”), a Delaware corporation, was incorporated in November 2000. The Company is a fabless provider of high-speed analog and mixed signal semiconductor solutions for the communications and cloud markets. The Company’s semiconductor solutions are designed to address bandwidth bottlenecks in networks, maximize throughput and minimize latency in computing environments and enable the rollout of next generation communications and cloud infrastructures. In addition, the semiconductor solutions provide a vital high-speed interface between analog signals and digital information in high-performance systems such as telecommunications transport systems, enterprise networking equipment and data centers.
On January 10, 2020, the Company completed the acquisition of eSilicon Corporation (“eSilicon”) for $214,644. The revenue and expenses of eSilicon from January 10, 2020 onwards are included in the condensed consolidated statement of income (loss).
On May 18, 2020, the Company purchased certain assets and rights of Arrive Technologies, Inc. ("Arrive") for $20,141. The revenue and expenses related to this purchase from May 18, 2020 onwards are included in the condensed consolidated statement of income (loss).
The interim unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. They do not include all of the information and footnotes required by GAAP for complete financial statements. Therefore, these interim unaudited condensed consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements and notes thereto for the year ended December 31, 2019, included in the Company’s Annual Report on Form 10-K filed with the Securities and Exchange Commission (“SEC”) on March 2, 2020.
The interim condensed consolidated financial statements included herein are unaudited; however, they contain all normal recurring accruals and adjustments that, in the opinion of management, are necessary to state fairly the Company’s consolidated financial position as of September 30, 2020, its consolidated results of operations and stockholders’ equity for the three and nine months ended September 30, 2020 and 2019, and cash flows for the nine months ended September 30, 2020 and 2019. The results of operations for the three and nine months ended September 30, 2020 are not necessarily indicative of the results to be expected for future quarters or the full year.
Use of Estimates and Judgments
The preparation of financial statements in conformity with GAAP requires management to make estimates and judgments that affect the amounts reported and disclosed in the condensed consolidated financial statements and accompanying notes. Actual results could differ materially from those estimates. On an ongoing basis, the Company evaluates its estimates and judgments compared to historical experience and expected trends. In March 2020, the outbreak of COVID-19 was declared a pandemic by the World Health Organization. While the nature of the situation is dynamic, the Company has considered the impact when developing its estimates and assumptions. Actual results and outcomes may differ from management's estimates and assumptions.
Revisions
As previously disclosed in the Company's Annual Report on Form 10-K for the year ended December 31, 2019, in connection with the preparation of the Company’s 2019 year-end consolidated financial statements, a classification error in the Company’s previously issued consolidated statements of cash flows was identified. Specifically, it was determined that payments made under the Company’s multiyear agreements for the purchase of internal use intangible assets should have been classified as use of cash for financing activities and not as use of cash for investing activities as originally presented. Such classification error had no impact on the Company’s consolidated balance sheets, statements of income (loss), statements of comprehensive income (loss) or statements of stockholders’ equity. Although the Company assessed the materiality of the error and concluded that the error was not material to the previously issued annual or interim financial statements, the Company did revise its previously issued 2018 and 2017 annual financial statements to correct for such classification error in connection with the filing of its 2019 Annual Report on Form 10-K, and disclosed that it would be revising its unaudited quarterly condensed consolidated statements of cash flows in connection with the filing of its Quarterly Reports on Form 10-Q in fiscal year 2020. In connection with the filing of this Quarterly Report on Form 10-Q, the Company has revised the accompanying 2019 unaudited condensed consolidated statement of cash flows to correct for such classification error. The effect of the revisions on the unaudited condensed consolidated statement of cash flows for the nine months ended September 30, 2019 was as follows: (i) cash used in investing activities decreased by $19,895 from $78,138 to $58,243, and (ii) cash used in financing activities increased by $19,895 from $17,751 to $37,646.
Summary of Significant Accounting Policies
Refer to the Company’s Annual Report on Form 10-K for a summary of significant accounting policies. On January 1, 2020, the Company adopted Accounting Standards Codification (“ASC”) Topic 326, Measurement of Credit Losses on Financial Instruments (“ASC 326”), and accordingly, modified its policy on accounting for allowance for doubtful accounts on trade accounts receivable and available-for-sale debt securities as stated below. As described under the “Recent Accounting Pronouncements” below, the impact of adopting ASC 326 for the Company was not material.
There have been no other significant changes to the Company’s significant accounting policies during the three and nine months ended September 30, 2020.
Accounts Receivable
The Company performs ongoing credit evaluations of its customers and assesses each customer’s credit worthiness. The Company monitors collections and payments from its customers and maintains an allowance for doubtful accounts based upon applying an expected credit loss rate to receivables based on the historical loss rate from similar high risk customers adjusted for current conditions, including any specific customer collection issues identified, and forecasts of economic conditions. Delinquent account balances are written off after management has determined that the likelihood of collection is remote. The allowance for credit losses as of September 30, 2020 was $1,202. The allowance for doubtful accounts as of December 31, 2019 was $1,152. The activities in this account, including the current-period provision for expected credit losses for the three and nine months ended September 30, 2020, were not material.
Inphi Corporation
Notes to Unaudited Condensed Consolidated Financial Statements
(Dollars in thousands except share and per share amounts)
Debt Securities
The Company performs an evaluation of its available-for-sale debt securities in unrealized loss position. The Company first assesses whether it intends to sell, or it is more likely than not that it will be required to sell the security before recovery of its amortized cost basis. If either of the criteria regarding intent or requirement to sell is met, the security's amortized cost basis is written down to fair value through the statement of income (loss). For available-for-sale debt securities that do not meet the aforementioned criteria, the Company evaluates whether the decline in fair value has resulted from credit losses or other factors. In making this assessment, the Company considers the extent to which fair value is less than amortized cost, any changes to the rating of the security by a rating agency, and adverse conditions specifically related to the security, among other factors. If this assessment indicates that a credit loss exists, the present value of cash flows expected to be collected from the security are compared to the amortized cost basis of the security. If the present value of cash flows expected to be collected is less than the amortized cost basis, a credit loss exists and an allowance for credit losses is recorded for the credit loss, limited by the amount that the fair value is less than the amortized cost basis. Changes in the allowance for credit losses are recorded as provision for (or reversal of) credit loss expense. Losses are charged against the allowance when the Company believes the uncollectibility of an available-for-sale security is confirmed or when either of the criteria regarding intent or requirement to sell is met. There was no allowance for credit loss as of September 30, 2020. Accrued interest receivable on available-for-sale debt securities as of September 30, 2020 was $454 and excluded from the estimate of credit losses. Accrued interest receivable on available-for-sale debt securities is reported within Prepaid expenses and other current assets on the condensed consolidated balance sheets. Any interest accrued that is past due by more than 90 days is written off through reversal of interest income.
2. Recent Accounting Pronouncements
In June 2016, the Financial Accounting Standards Board (“FASB”) issued ASC 326, to replace the incurred loss methodology with an expected credit loss model that requires consideration of a broader range of information to estimate credit losses over the lifetime of the asset, including current conditions and reasonable and supportable forecasts in addition to historical loss information, to determine expected credit losses. Pooling of assets with similar risk characteristics and the use of a loss model are also required. Also, in April 2019, the FASB issued ASU No. 2019-04, Codification Improvements to Topic 326, Financial Instruments—Credit Losses, Topic 815, Derivatives and Hedging, and Topic 825, Financial Instruments, to clarify the inclusion of recoveries of trade receivables previously written off when estimating an allowance for credit losses. The guidance is effective for the Company beginning with fiscal year 2020, including interim periods. The adoption of this guidance did not have a material impact on the Company’s consolidated financial statements.
In August 2018, the FASB issued guidance that eliminates certain disclosure requirements for fair value measurements for all entities, requiring public entities to disclose certain new information and modifies some disclosure requirements. The new guidance will no longer require disclosure of the amount of and reasons for transfers between Level 1 and Level 2 of the fair value hierarchy, but will require disclosure of the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements. The guidance will be effective for fiscal years beginning after December 15, 2019. The Company adopted this guidance on January 1, 2020. The adoption of this standard did not have a material impact on the Company’s consolidated financial statements.
In August 2018, the FASB issued guidance requiring a customer in a cloud computing arrangement under a service contract to follow the internal use software guidance in ASC 350-40 to determine which implementation costs to capitalize as assets. Capitalized implementation costs are expensed over the term of the hosting arrangement beginning when the module or component of the hosting arrangement is ready for its intended use. The guidance will be effective for fiscal years beginning after December 15, 2019. The Company adopted this guidance on January 1, 2020. The adoption of this standard did not have a material impact on the Company’s consolidated financial statements.
In November 2018, the FASB issued amendments to guidance on “Collaborative Arrangements” and “Revenue from Contracts with Customers”, that require transactions in collaborative arrangements to be accounted for under “Revenue from Contracts with Customers” if the counterparty is a customer for a good or service (or bundle of goods and services) that is a distinct unit of account. The amendments also preclude entities from presenting consideration from transactions with a collaborator that is not a customer together with revenue recognized from contracts with customers. The amendments to the guidance are effective for fiscal years beginning after December 15, 2019, and interim periods within those fiscal years. The Company adopted this guidance on January 1, 2020. The adoption of this standard did not have a material impact on the Company’s consolidated financial statements.
In December 2019, the FASB issued guidance that simplifies the accounting for income taxes as part of FASB's overall initiative to reduce complexity in accounting standards. Amendments include removal of certain exceptions to the general principles of ASC 740, Income Taxes, and simplification in general other areas such as accounting for a franchise tax (or similar tax) that is partially based on income. The guidance will be effective for fiscal years beginning after December 15, 2020, though early adoption is permitted. The Company is currently evaluating the impact that this new guidance will have on its consolidated financial statements.
In August 2020, the FASB issued guidance that simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts on an entity’s own equity. The guidance will reduce the number of accounting models for convertible debt instruments and convertible preferred stock. This will result in fewer embedded conversion features being separately recognized from the host contract compared with current GAAP. More convertible debt instruments will be reported as a single liability instrument, and more convertible preferred stock will be reported as a single equity instrument with no separate accounting for embedded conversion features. FASB also made changes to the disclosures for convertible instruments and earnings-per-share guidance. The guidance will be effective for fiscal years beginning after December 15, 2021, though early adoption is permitted. The Company is currently evaluating the impact that this new guidance will have on its consolidated financial statements.
3. Acquisitions
eSilicon
On January 10, 2020, the Company completed the acquisition of eSilicon for approximately $214,644. The Company acquired eSilicon to accelerate the Company’s roadmap in developing electro-optics solutions for cloud and telecommunications customers. An amount of $10,000 was placed in an escrow fund for 12 months (up to 36 months in certain circumstances) following the closing for the satisfaction of certain potential indemnification claims. The condensed consolidated financial statements include the results of operations of eSilicon from the acquisition date.
The acquisition has been accounted for using the purchase method of accounting, which requires, among other things, that assets acquired and liabilities assumed be recognized at their fair values as of the acquisition date. The Company allocated the purchase price to tangible and intangible assets acquired and liabilities assumed based on their estimated fair values. The fair value of identifiable intangible assets acquired was based on estimates and assumptions made by management at the time of acquisition. As additional information becomes available, such as finalization of the estimated fair value of tax related items, the Company
may revise the preliminary purchase price allocation during the measurement period (which will
not exceed
12 months from the acquisition date). Any such revisions or changes
may be material as the Company finalizes the fair values of the tangible and intangible assets acquired and liabilities assumed.
Inphi Corporation
Notes to Unaudited Condensed Consolidated Financial Statements
(Dollars in thousands except share and per share amounts)
The following table summarizes the preliminary purchase price allocation as of the acquisition date:
Cash
|
|
$
|
704
|
|
Restricted cash
|
|
|
2,100
|
|
Accounts receivable
|
|
|
5,750
|
|
Inventories
|
|
|
21,086
|
|
Prepaid expenses and other current assets
|
|
|
21,012
|
|
Property and equipment
|
|
|
7,106
|
|
Intangible assets
|
|
|
148,720
|
|
Right of use asset
|
|
|
1,022
|
|
Other noncurrent assets
|
|
|
252
|
|
Accounts payable
|
|
|
(9,105
|
)
|
Accrued expenses
|
|
|
(25,060
|
)
|
Deferred revenue
|
|
|
(7,501
|
)
|
Other current liabilities
|
|
|
(13,886
|
)
|
Other liabilities
|
|
|
(3,567
|
)
|
Total identifiable net assets
|
|
$
|
148,633
|
|
Goodwill
|
|
|
66,011
|
|
Net assets acquired
|
|
$
|
214,644
|
|
As of the acquisition date, the fair value of receivables, other assets, accounts payable, accrued expenses and other liabilities approximated the book value acquired.
The following table summarizes the estimated fair value of intangible assets and their estimated useful lives as of the date of acquisition:
|
|
Estimated Fair Value
|
|
|
Estimated Useful Life (Years)
|
|
Contract manufacturing rights
|
|
$
|
105,160
|
|
|
|
5.0
|
|
Developed technology
|
|
|
33,630
|
|
|
|
8.0
|
|
Software
|
|
|
9,930
|
|
|
|
0.5 to 2.0
|
|
|
|
$
|
148,720
|
|
|
|
|
|
Developed technology was valued using the multi-period excess earnings method under the income approach. This method involves discounting the direct cash flows expected to be generated by the technologies over their remaining lives, net of returns on contributory assets. The estimated useful life was determined based on the technology cycle related to product family and its expected contribution to forecasted revenue. Contract manufacturing rights were valued using a multi-period excess earnings method, which involved discounting the direct cash flow expected to be generated by these rights over their remaining economic lives, net of returns on contributory assets. The estimated useful life was determined to be five years based on the estimated life of the product, assuming that the existing customers will remain with the Company until the product becomes obsolete. The cash flows for the two intangible assets were distinctly separate and bifurcated for the purposes of the valuation of each asset.
Goodwill is calculated as the excess of the consideration transferred over the net assets recognized and is attributable to the workforce of eSilicon, the Company’s going concern value with the opportunity to leverage its workforce to develop new technologies and the ability of the Company to grow the business faster and more profitable than was possible by eSilicon as a stand-alone company. Goodwill is not amortized and is not deductible for tax purposes.
The Company incurred acquisition costs of $1,550, of which $1,015 was incurred in the year ended December 31, 2019 and $535 was included in general and administrative expense in the condensed consolidated statement of income (loss) for the nine months ended September 30, 2020.
eSilicon contributed revenue of $31,455 and pre-tax income of $1,108 to the Company for the three months ended September 30, 2020. eSilicon contributed revenue of $91,306 and pre-tax loss of $13,884 for the period from January 10, 2020 to September 30, 2020.
Prior to the acquisition, the Company owned a minority equity interest in eSilicon. The fair value of the equity interest immediately before the acquisition date was $14,999, which resulted in a gain of $4,999 and was included in Other income, net in the condensed consolidated statement of income (loss) for the nine months ended September 30, 2020. The fair value was determined based on the proceeds received as a holder of eSilicon's preferred stock.
Arrive
On May 18, 2020, the Company purchased certain assets and rights of Arrive for $20,141. The Company acquired Arrive for the purpose of expanding its presence into strategic geographic regions for talent acquisition. An amount of $3,000 was withheld by the Company for 12 months following the closing for the satisfaction of certain potential indemnification claims. The condensed consolidated financial statements include the results of operations of Arrive from the acquisition date.
Inphi Corporation
Notes to Unaudited Condensed Consolidated Financial Statements
(Dollars in thousands except share and per share amounts)
The acquisition has been accounted for using the purchase method of accounting, which requires, among other things, that assets acquired and liabilities assumed be recognized at their fair values as of the acquisition date. The Company allocated the purchase price to tangible and intangible assets acquired based on their estimated fair values. The fair value of the identifiable intangible asset acquired was based on estimates and assumptions made by management at the time of acquisition. As additional information becomes available, such as finalization of the estimated fair value of tax related items, the Company
may revise the preliminary purchase price allocation during the measurement period (which will
not exceed
12 months from the acquisition date). Any such revisions or changes
may be material as the Company finalizes the fair values of the tangible and intangible assets acquired.
The following table summarizes the preliminary purchase price allocation as of the acquisition date:
Inventories
|
|
$
|
126
|
|
Intangible asset
|
|
|
8,840
|
|
Total identifiable net assets
|
|
|
8,966
|
|
Goodwill
|
|
|
11,175
|
|
Net assets acquired
|
|
$
|
20,141
|
|
The estimated fair value of developed technology was $8,840 with an estimated useful life of five years. The developed technology was valued using the multi-period excess earnings method under the income approach. This method involves discounting the direct cash flows expected to be generated by the technologies over their remaining lives, net of returns on contributory assets. The estimated useful life was determined to be five years based on the estimated life of the product, assuming that the existing customers will remain with the Company until the product becomes obsolete.
Goodwill is calculated as the excess of the consideration transferred over the net assets recognized and is attributable to the workforce of Arrive, the Company’s going concern value with the opportunity to leverage its workforce to develop new technologies and the ability of the Company to grow the business faster and more profitable than was possible by Arrive as a stand-alone company. Since this is an asset purchase agreement, the goodwill is amortized and is deductible for tax purposes.
The Company incurred acquisition costs of $180 included in general and administrative expense in the condensed consolidated statement of income (loss) for the nine months ended September 30, 2020.
Arrive contributed revenue of $975 and pre-tax loss of $1,087 to the Company for the three months ended September 30, 2020. Arrive contributed revenue of $1,546 and pre-tax loss of $1,207 to the Company for the period from May 18, 2020 to September 30, 2020.
Pro Forma Information
The following unaudited pro forma financial information presents a summary of the Company’s condensed consolidated results of operations for the three and nine months ended September 30, 2020 and 2019, assuming the eSilicon and Arrive acquisitions have been completed as of January 1, 2019. The pro forma information includes adjustments to revenue, amortization and depreciation for intangible assets and property and equipment acquired, amortization of the purchase accounting effect on inventory acquired from eSilicon and interest income for reduction in short-term investments to fund the acquisition.
|
|
Pro Forma Three Months Ended
|
|
|
Pro Forma Nine Months Ended
|
|
|
|
September 30, 2020
|
|
|
September 30, 2019
|
|
|
September 30, 2020
|
|
|
September 30, 2019
|
|
|
|
(unaudited)
|
|
(unaudited)
|
|
Revenue
|
|
$
|
180,691
|
|
|
$
|
121,206
|
|
|
$
|
502,892
|
|
|
$
|
344,433
|
|
Net loss
|
|
$
|
(2,447
|
)
|
|
$
|
(25,497
|
)
|
|
$
|
(50,328
|
)
|
|
$
|
(110,400
|
)
|
The unaudited pro forma financial information was prepared using the acquisition method of accounting and are based on the historical financial information of the Company, eSilicon and Arrive, reflecting the results of operations for the three and nine months ended September 30, 2020 and 2019. The unaudited pro forma financial information is not necessarily indicative of what the Company’s consolidated results of operations actually would have been had the Company completed the acquisitions as of the beginning of the period presented. In addition, the unaudited pro forma financial information does not purport to project the future results of operations of the combined company nor do they reflect the expected realization of any cost savings associated with the acquisitions.
Inphi Corporation
Notes to Unaudited Condensed Consolidated Financial Statements
(Dollars in thousands except share and per share amounts)
4. Investments
The following table summarizes the investments in marketable securities by investment category:
|
|
September 30, 2020
|
|
|
December 31, 2019
|
|
|
|
Cost
|
|
|
Fair Value
|
|
|
Cost
|
|
|
Fair Value
|
|
Available-for-sale securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. Treasury securities
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
3,752
|
|
|
$
|
3,759
|
|
Municipal bonds
|
|
|
18,963
|
|
|
|
19,093
|
|
|
|
6,062
|
|
|
|
6,119
|
|
Corporate notes/bonds
|
|
|
49,325
|
|
|
|
49,925
|
|
|
|
118,859
|
|
|
|
119,449
|
|
Asset backed securities
|
|
|
2,500
|
|
|
|
2,520
|
|
|
|
4,239
|
|
|
|
4,268
|
|
Commercial paper
|
|
|
3,538
|
|
|
|
3,539
|
|
|
|
6,464
|
|
|
|
6,464
|
|
Certificate of deposit
|
|
|
—
|
|
|
|
—
|
|
|
|
72
|
|
|
|
72
|
|
Total investments
|
|
$
|
74,326
|
|
|
$
|
75,077
|
|
|
$
|
139,448
|
|
|
$
|
140,131
|
|
As of September 30, 2020, there were no investments that had an unrealized loss position. The Company reviews the investments to identify and evaluate investments that have an indication of possible other-than-temporary impairment. Factors considered in determining whether a loss is other-than-temporary include the extent to which fair value has been less than the cost basis, the financial condition and near-term prospects of the investee, and the intent and ability to hold the investment for a period of time sufficient to allow for any anticipated recovery in market value.
The contractual maturities of available-for-sale securities at September 30, 2020 are presented in the following table:
|
|
Cost
|
|
|
Fair Value
|
|
Due in one year or less
|
|
$
|
58,928
|
|
|
$
|
59,357
|
|
Due between one and five years
|
|
|
15,398
|
|
|
|
15,720
|
|
|
|
$
|
74,326
|
|
|
$
|
75,077
|
|
The Company has a marketable equity investment in a company located in Taiwan. The fair value of the investment and unrealized loss as of September 30, 2020 was $1,804 and $190, respectively. The fair value of the investment and unrealized loss as of December 31, 2019 was $1,662 and $332, respectively. This investment is included in Other assets, net in the condensed consolidated balance sheets.
The Company has non-marketable equity investments in privately held companies without readily determinable market values. The Company adjusts the carrying value of non-marketable equity investments to fair value upon observable transactions for identical or similar investments of the same issuer or impairment (referred to as the measurement alternative). All gains and losses on non-marketable equity investments, realized and unrealized, are recognized in Other income, net in the condensed consolidated statement of income (loss). As of September 30, 2020, non-marketable equity investments had a carrying value of approximately $23,593, of which $11,093 was remeasured to fair value based on an observable transaction during the nine months ended September 30, 2020. These investments are included in Other assets, net in the condensed consolidated balance sheets. An unrealized gain of $1,801 was recorded in Other income and included as an adjustment to the carrying value of non-marketable equity investments for the nine months ended September 30, 2020.
5. Inventories
Inventories consist of the following:
|
|
September 30, 2020
|
|
|
December 31, 2019
|
|
Raw materials
|
|
$
|
49,900
|
|
|
$
|
18,593
|
|
Work in process
|
|
|
36,178
|
|
|
|
19,081
|
|
Finished goods
|
|
|
22,487
|
|
|
|
17,339
|
|
|
|
$
|
108,565
|
|
|
$
|
55,013
|
|
6. Property and Equipment, net
Property and equipment consist of the following:
|
|
September 30, 2020
|
|
|
December 31, 2019
|
|
Laboratory and production equipment
|
|
$
|
183,647
|
|
|
$
|
144,866
|
|
Office, software and computer equipment
|
|
|
46,261
|
|
|
|
37,241
|
|
Furniture and fixtures
|
|
|
1,869
|
|
|
|
1,617
|
|
Leasehold improvements
|
|
|
20,351
|
|
|
|
8,282
|
|
|
|
|
252,128
|
|
|
|
192,006
|
|
Less accumulated depreciation and amortization
|
|
|
(125,951
|
)
|
|
|
(112,443
|
)
|
|
|
$
|
126,177
|
|
|
$
|
79,563
|
|
Inphi Corporation
Notes to Unaudited Condensed Consolidated Financial Statements
(Dollars in thousands except share and per share amounts)
Depreciation and amortization expense of property and equipment for the three and nine months ended September 30, 2020 was $6,540 and $19,805, respectively. Depreciation and amortization expense of property and equipment for the three and nine months ended September 30, 2019 was $5,668 and $16,726, respectively.
As of September 30, 2020 and December 31, 2019, computer software costs included in property and equipment were $8,222 and $7,339, respectively. Amortization expense of capitalized computer software costs was $254 and $757 for the three and nine months ended September 30, 2020, respectively. Amortization expense of capitalized computer software costs was $94 and $280 for the three and nine months ended September 30, 2019, respectively.
Property and equipment not yet paid in cash as of September 30, 2020 and December 31, 2019 was $11,010 and $4,728, respectively.
7. Intangible Assets
The following table presents details of intangible assets:
|
|
September 30, 2020
|
|
|
December 31, 2019
|
|
|
|
Gross
|
|
|
Accumulated Amortization
|
|
|
Net
|
|
|
Gross
|
|
|
Accumulated Amortization
|
|
|
Net
|
|
Developed technology
|
|
$
|
229,270
|
|
|
$
|
144,368
|
|
|
$
|
84,902
|
|
|
$
|
186,800
|
|
|
$
|
123,365
|
|
|
$
|
63,435
|
|
Customer relationships
|
|
|
70,540
|
|
|
|
38,704
|
|
|
|
31,836
|
|
|
|
70,540
|
|
|
|
31,409
|
|
|
|
39,131
|
|
Contract manufacturing rights
|
|
|
102,388
|
|
|
|
14,795
|
|
|
|
87,593
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
Trade name
|
|
|
2,310
|
|
|
|
1,974
|
|
|
|
336
|
|
|
|
2,310
|
|
|
|
1,766
|
|
|
|
544
|
|
Patents
|
|
|
1,579
|
|
|
|
1,086
|
|
|
|
493
|
|
|
|
1,579
|
|
|
|
1,010
|
|
|
|
569
|
|
Software
|
|
|
79,075
|
|
|
|
28,065
|
|
|
|
51,010
|
|
|
|
74,022
|
|
|
|
9,411
|
|
|
|
64,611
|
|
|
|
$
|
485,162
|
|
|
$
|
228,992
|
|
|
$
|
256,170
|
|
|
$
|
335,251
|
|
|
$
|
166,961
|
|
|
$
|
168,290
|
|
The following table presents amortization of intangible assets for the three and nine months ended September 30, 2020 and 2019:
|
|
Three Months Ended September 30,
|
|
|
Nine Months Ended September 30,
|
|
|
|
2020
|
|
|
2019
|
|
|
2020
|
|
|
2019
|
|
Cost of goods sold
|
|
$
|
12,380
|
|
|
$
|
9,724
|
|
|
$
|
35,938
|
|
|
$
|
29,172
|
|
Research and development
|
|
|
7,083
|
|
|
|
5,806
|
|
|
|
20,667
|
|
|
|
16,722
|
|
Sales and marketing
|
|
|
2,432
|
|
|
|
2,432
|
|
|
|
7,296
|
|
|
|
7,296
|
|
General and administrative
|
|
|
93
|
|
|
|
147
|
|
|
|
285
|
|
|
|
445
|
|
|
|
$
|
21,988
|
|
|
$
|
18,109
|
|
|
$
|
64,186
|
|
|
$
|
53,635
|
|
Based on the amount of intangible assets subject to amortization at September 30, 2020, the expected amortization expense for each of the next five fiscal years and thereafter is as follows:
2020 (remaining)
|
|
$
|
21,942
|
|
2021
|
|
|
80,982
|
|
2022
|
|
|
69,614
|
|
2023
|
|
|
42,365
|
|
2024
|
|
|
27,122
|
|
Thereafter
|
|
|
14,145
|
|
|
|
$
|
256,170
|
|
The weighted-average amortization periods remaining by intangible asset category were as follows (in years):
Developed technology
|
|
|
4.4
|
|
Customer relationship
|
|
|
3.3
|
|
Contract manufacturing rights
|
|
|
4.3
|
|
Trade name
|
|
|
1.2
|
|
Patents
|
|
|
7.2
|
|
Software
|
|
|
2.0
|
|
Inphi Corporation
Notes to Unaudited Condensed Consolidated Financial Statements
(Dollars in thousands except share and per share amounts)
8. Leases
The Company has operating leases for office facilities. The leases have remaining lease terms of one year to ten years and some may include options to extend the lease for up to five years.
Information related to operating leases are as follows:
|
|
Three Months Ended September 30,
|
|
|
Nine Months Ended September 30,
|
|
|
|
2020
|
|
|
2019
|
|
|
2020
|
|
|
2019
|
|
Operating lease cost
|
|
$
|
2,394
|
|
|
$
|
1,170
|
|
|
$
|
6,920
|
|
|
$
|
3,268
|
|
Cash paid for leases
|
|
|
1,820
|
|
|
|
1,028
|
|
|
|
5,147
|
|
|
|
3,219
|
|
Right of use assets obtained in exchange for lease obligations
|
|
|
418
|
|
|
|
2,927
|
|
|
|
4,161
|
|
|
|
3,151
|
|
Weighted average remaining lease term and weighted average discount are as follows:
|
|
September 30, 2020
|
|
|
December 31, 2019
|
|
Weighted average remaining lease term (years)
|
|
|
7.88
|
|
|
|
8.52
|
|
Weighted average discount rate
|
|
|
3.8
|
%
|
|
|
3.9
|
%
|
Future minimum lease payments under non-cancellable leases as of September 30, 2020 are as follows:
2020 (remaining)
|
|
$
|
1,785
|
|
2021
|
|
|
6,878
|
|
2022
|
|
|
7,087
|
|
2023
|
|
|
7,050
|
|
2024
|
|
|
6,734
|
|
Thereafter
|
|
|
23,984
|
|
Total future minimum lease payments
|
|
|
53,518
|
|
Less: Imputed interest
|
|
|
7,896
|
|
Lease incentive recognized as offset to lease liability
|
|
|
3,139
|
|
Present value of lease obligations
|
|
$
|
42,483
|
|
Inphi Corporation
Notes to Unaudited Condensed Consolidated Financial Statements
(Dollars in thousands except share and per share amounts)
9. Product Warranty Obligation
As of September 30, 2020 and December 31, 2019, the product warranty liability was $110. There was no change in product warranty liability during the three and nine months ended September 30, 2020 and 2019.
10. Convertible Debt
The carrying amount of the Company’s long-term debt consists of the following:
|
|
September 30, 2020
|
|
|
December 31, 2019
|
|
Principal
|
|
$
|
617,737
|
|
|
$
|
517,500
|
|
Less:
|
|
|
|
|
|
|
|
|
Unamortized debt discount
|
|
|
(99,360
|
)
|
|
|
(38,105
|
)
|
Unamortized debt issuance costs
|
|
|
(10,252
|
)
|
|
|
(3,217
|
)
|
Net carrying amount of long-term debt
|
|
|
508,125
|
|
|
|
476,178
|
|
Less current portion of long-term debt
|
|
|
107,699
|
|
|
|
217,467
|
|
Long-term debt, non-current portion
|
|
$
|
400,426
|
|
|
$
|
258,711
|
|
In December 2015, the Company issued $230,000 of 1.125% convertible senior notes due 2020 (the “Convertible Notes 2015”). The Convertible Notes 2015 will mature December 1, 2020, unless earlier converted or repurchased. Interest on the Convertible Notes 2015 is payable on June 1 and December 1 of each year, beginning on June 1, 2016. The initial conversion rate is 24.8988 shares of common stock per $1 principal amount of Convertible Notes 2015, which represents an initial conversion price of approximately $40.16 per share.
Interest expense for the Convertible Notes 2015 are as follows:
|
|
Three Months Ended September 30,
|
|
|
Nine Months Ended September 30,
|
|
|
|
2020
|
|
|
2019
|
|
|
2020
|
|
|
2019
|
|
Contractual interest expense
|
|
$
|
139
|
|
|
$
|
650
|
|
|
$
|
1,152
|
|
|
$
|
1,936
|
|
Amortization of debt discount
|
|
|
686
|
|
|
|
2,960
|
|
|
|
5,426
|
|
|
|
8,627
|
|
Amortization of debt issuance costs
|
|
|
62
|
|
|
|
267
|
|
|
|
489
|
|
|
|
777
|
|
Total interest expense
|
|
$
|
887
|
|
|
$
|
3,877
|
|
|
$
|
7,067
|
|
|
$
|
11,340
|
|
In connection with the issuance of the Convertible Notes 2015, the Company entered into capped call transactions (the “Capped Call 2015”) in private transactions. Under the Capped Call 2015, the Company purchased capped call options that in aggregate relate to 100% of the total number of shares of the Company's common stock underlying the Convertible Notes 2015, with a strike price approximately equal to the conversion price of the Convertible Notes 2015 and with a cap price equal to $52.06 per share.
Inphi Corporation
Notes to Unaudited Condensed Consolidated Financial Statements
(Dollars in thousands except share and per share amounts)
In September 2016, the Company issued $287,500 of 0.75% convertible senior notes due 2021 (the “Convertible Notes 2016”). The Convertible Notes 2016 will mature on September 1, 2021, unless earlier converted or repurchased. Interest on the Convertible Notes 2016 is payable on March 1 and September 1 of each year, beginning on March 1, 2017. The initial conversion rate is 17.7508 shares of common stock per $1 principal amount of the Convertible Notes 2016, which represents an initial conversion price of approximately $56.34 per share.
Interest expense for the Convertible Notes 2016 are as follows:
|
|
Three Months Ended September 30,
|
|
|
Nine Months Ended September 30,
|
|
|
|
2020
|
|
|
2019
|
|
|
2020
|
|
|
2019
|
|
Contractual interest expense
|
|
$
|
110
|
|
|
$
|
541
|
|
|
$
|
1,044
|
|
|
$
|
1,608
|
|
Amortization of debt discount
|
|
|
855
|
|
|
|
3,682
|
|
|
|
7,504
|
|
|
|
10,732
|
|
Amortization of debt issuance costs
|
|
|
70
|
|
|
|
302
|
|
|
|
615
|
|
|
|
879
|
|
Total interest expense
|
|
$
|
1,035
|
|
|
$
|
4,525
|
|
|
$
|
9,163
|
|
|
$
|
13,219
|
|
In connection with the issuance of the Convertible Notes 2016, the Company entered into capped call transactions (the “Capped Call 2016”) in private transactions. Under the Capped Call 2016, the Company purchased capped call options that in aggregate relate to 100% of the total number of shares of the Company's common stock underlying the Convertible Notes 2016, with a strike price approximately equal to the conversion price of the Convertible Notes 2016 and with a cap price equal to approximately $73.03 per share.
In April 2020, the Company issued $506,000 of 0.75% convertible senior notes due 2025 (“Convertible Notes 2020” and, together with the Convertible Notes 2015 and Convertible Notes 2016, the “Convertible Notes”). The Convertible Notes 2020 will mature April 15, 2025, unless earlier converted or repurchased. Interest on the Convertible Notes 2020 is payable on April 15 and October 15 of each year, beginning on October 15, 2020. The initial conversion rate is 8.0059 shares of common stock per $1 principal amount of Convertible Notes 2020, which represents an initial conversion price of approximately $124.91 per share. The Convertible Notes 2020 will be subject to repurchase at the option of the holders following certain fundamental corporate changes, at a fundamental change in repurchase price equal to 100% of the principal amount of the notes to be repurchased, plus accrued and unpaid interest to, but excluding, the fundamental change repurchase date. The conversion rate will be subject to adjustment in some events but will not be adjusted for any accrued and unpaid interest. Certain corporate events that occur prior to the stated maturity date can cause the Company to increase the conversion rate for a holder.
Prior to the close of business on the business day immediately preceding October 15, 2024, holders may convert all or any portion of their Convertible Notes 2020 only under the following circumstances: (i) during any calendar quarter commencing after the calendar quarter ending on June 30, 2020 (and only during such calendar quarter), if the last reported sale price of the Company’s common stock, for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the conversion price for the Convertible Notes 2020 on each applicable trading day; (ii) during the five business day period after any five consecutive trading day period (the “measurement period”) in which the trading price (as defined in the Indenture 2020 (as defined below)) per $1 principal amount of Convertible Notes 2020 for each trading day of the measurement period was less than 98% of the product of the last reported sale price of the common stock and the conversion rate on each such trading day; (iii) if the Company calls any or all of the Convertible Notes 2020 for redemption, at any time prior to the close of business on the second scheduled trading day immediately preceding the redemption date; or (iv) upon the occurrence of specified corporate events. On or after October 15, 2024 until the close of business on the second scheduled trading day immediately preceding the maturity date, holders may convert their Convertible Notes 2020 at any time, regardless of the foregoing circumstances. Upon conversion of a Convertible Notes 2020, the Company will pay or deliver, as the case may be, cash, shares of common stock or a combination of cash and shares of common stock, at the Company’s election. The Company's current intent is to settle the principal amount of the Convertible Notes 2020 in cash upon conversion. If the conversion value exceeds the principal amount, the Company would deliver shares of its common stock in respect to the remainder of its conversion obligation in excess of the aggregate principal amount.
The Company
may
not redeem the Convertible Notes
2020 prior to
April 20, 2023. The Company
may redeem for cash all or any portion of the Convertible Notes
2020, at its option, on or after
April 20, 2023 if the last reported sale price of the common stock has been at least
130% of the conversion price then in effect for at least
20 trading days (whether or
not consecutive) during any
30 consecutive trading day period (including the last trading day of such period) ending on, and including, the trading day immediately preceding the date on which the Company provides notice of redemption at a redemption price equal to
100% of the principal amount of the Convertible Notes
2020 to be redeemed, plus accrued and unpaid interest to, but excluding, the redemption date.
Upon the occurrence of certain fundamental changes, the holders of the Convertible Notes 2020 may require the Company to repurchase all or a portion of the Convertible Notes 2020 for cash at a price equal to 100% of the principal amount of the Convertible Notes 2020, plus accrued and unpaid interest to, but excluding, the fundamental change repurchase date.
Inphi Corporation
Notes to Unaudited Condensed Consolidated Financial Statements
(Dollars in thousands except share and per share amounts)
The Convertible Notes 2020 are governed by an Indenture dated April 24, 2020 (the “Indenture 2020”) between the Company and U.S. Bank National Association, as trustee (the “Trustee”). The Indenture 2020 does not contain any financial or operating covenants, or restrictions on the payments of dividends, the incurrence of indebtedness or the issuance or repurchase of securities by the Company or any of its subsidiaries. The Indenture 2020 contains customary terms and covenants, including that upon certain events of default occurring and continuing, either the Trustee or the holders of not less than 25% in aggregate principal amount of the Convertible Notes 2020 then outstanding may declare 100% of the principal of and accrued and unpaid interest, if any, on all the Convertible Notes 2020, to be due and payable. Upon events of default involving specified bankruptcy events involving the Company, 100% of the principal of and accrued and unpaid interest, if any, on all of the Convertible Notes 2020 will be due and payable immediately. Notwithstanding the foregoing, the Indenture 2020 provides that, to the extent the Company elects, the sole remedy for an event of default relating to certain failures by the Company to comply with certain reporting covenants in the Indenture 2020 consists exclusively of the right to receive additional interest on the Convertible Notes 2020. As of September 30, 2020, none of the conditions allowing holders of the Convertible Notes 2020 to convert had been met.
In accounting for the issuance of the Convertible Notes 2020, the Company separated the Convertible Notes 2020 into liability and equity components. The carrying amount of the liability component was calculated by measuring the estimated fair value of a similar liability that does not have an associated convertible feature. The carrying amount of the equity component representing the conversion option was determined by deducting the fair value of the liability component from the face value of the Convertible Notes 2020 as a whole. The excess of the face amount of the liability component over its carrying amount is amortized to interest expense over the term of the Convertible Notes 2020 using the effective interest method. The gross proceeds of $506,000 were accordingly allocated between long-term debt of $402,624 and stockholders' equity of $103,376. Issuance costs of $13,507 were allocated between long-term debt of $10,747 and equity of $2,760.
Interest expense for the Convertible Notes 2020 for the three and nine months ended September 30, 2020 are as follows:
|
|
Three Months Ended September 30, 2020
|
|
|
Nine Months Ended September 30, 2020
|
|
Contractual interest expense
|
|
$
|
1,042
|
|
|
$
|
1,801
|
|
Amortization of debt discount
|
|
|
4,511
|
|
|
|
7,745
|
|
Amortization of debt issuance costs
|
|
|
469
|
|
|
|
805
|
|
Total interest expense
|
|
$
|
6,022
|
|
|
$
|
10,351
|
|
In connection with the issuance of the Convertible Notes 2020, the Company entered into capped call transactions (“Capped Call 2020”) in private transactions. Under the Capped Call 2020, the Company purchased capped call options that in aggregate relate to 100% of the total number of shares of the Company's common stock underlying the Convertible Notes 2020, with a strike price approximately equal to the conversion price of the Convertible Notes 2020 and with a cap price equal to $188.54 per share. The Capped Call 2020 were purchased for $55,660 and recorded as a reduction to additional paid-in-capital in accordance with ASC 815-40, Contracts in Entity’s Own Equity.
The purchased Capped Call 2020 allows the Company to receive shares of its common stock and/or cash from counterparties equal to the amounts of common stock and/or cash related to the excess of the market price per share of the common stock, as measured under the terms of the Capped Call 2020 over the strike price of the Capped Call 2020 during the relevant valuation period. The purchased Capped Call 2020 is intended to reduce the potential dilution to common stock upon future conversion of the Convertible Notes 2020 by effectively increasing the initial conversion price to $188.54 as well as to offset potential cash payments the Company is required to make in excess of the principal amount of the Convertible Notes 2020 in applicable events.
The Capped Call 2020 is a separate transaction entered into by the Company with the option counterparties, is not part of the terms of the Convertible Notes 2020 and will not change the holders' rights under the Convertible Notes 2020.
During the three months ended June 30, 2020, the Company repurchased $180,454 and $223,090 aggregate principal amount of the Convertible Notes 2015 and Convertible Notes 2016, respectively. During the three months ended September 30, 2020, the Company repurchased $2,219 aggregate principal amount of the Convertible Notes 2016. The repurchase was accounted for as debt extinguishment. The Company paid a total of $410,002 cash (excluding payment for accrued interest) and issued a total of 4,963,135 shares of common stock. The total repurchase consideration was allocated to the liability and equity components of respective Convertible Notes. The total repurchase consideration allocated to the liability component was based on the fair value of the liability component using discount rates based on the Company's estimated rate for a similar liability with the same maturity, but without the conversion option. The repurchase consideration allocated to the equity component was calculated by deducting the fair value of the liability component from the aggregate repurchase consideration. The loss on extinguishment was determined by comparing the allocated purchase consideration with the carrying value of the liability component, which includes the proportionate amounts of unamortized debt discount and the remaining unamortized debt issuance costs.
Inphi Corporation
Notes to Unaudited Condensed Consolidated Financial Statements
(Dollars in thousands except share and per share amounts)
The net carrying amount of the liability component of the convertible debt immediately prior to the repurchase was as follows:
|
|
Convertible Notes 2015
|
|
|
Convertible Notes 2016
|
|
Principal
|
|
$
|
180,454
|
|
|
$
|
225,309
|
|
Unamortized debt discount
|
|
|
(5,596
|
)
|
|
|
(15,850
|
)
|
Unamortized debt issuance costs
|
|
|
(504
|
)
|
|
|
(1,299
|
)
|
Total
|
|
$
|
174,354
|
|
|
$
|
208,160
|
|
The loss on early extinguishment of debt is calculated as follows:
|
|
Convertible Notes 2015
|
|
|
Convertible Notes 2016
|
|
Repurchase consideration allocated to the liability component
|
|
$
|
177,622
|
|
|
$
|
218,338
|
|
Net carrying value of debt
|
|
|
(174,354
|
)
|
|
|
(208,160
|
)
|
Loss on early extinguishment
|
|
$
|
3,268
|
|
|
$
|
10,178
|
|
The repurchase consideration allocated to the equity component of $299,458 and $272,348 for the Convertible Notes 2015 and Convertible Notes 2016, respectively, was recorded as a reduction to additional paid-in capital in the Company's balance sheet. The total value of common stock issued in relation to the repurchases was $295,660 and $262,105 for the Convertible Notes 2015 and Convertible Notes 2016, respectively.
The conversion condition for the Convertible Notes 2015 and Convertible Notes 2016 was met during the three months ended September 30, 2020. During the three months ended September 30, 2020, the Company received conversion requests on the aggregate principal amount for the Convertible Notes 2016 of $1,674, which remain unsettled as of September 30, 2020.
11. Other Liabilities
Other current liabilities consist of the following:
|
|
September 30, 2020
|
|
|
December 31, 2019
|
|
Software license agreements liability
|
|
$
|
25,292
|
|
|
$
|
25,810
|
|
Operating lease liability
|
|
|
2,321
|
|
|
|
2,545
|
|
Others
|
|
|
16,104
|
|
|
|
5,176
|
|
|
|
$
|
43,717
|
|
|
$
|
33,531
|
|
Inphi Corporation
Notes to Unaudited Condensed Consolidated Financial Statements
(Dollars in thousands except share and per share amounts)
Other long-term liabilities consist of the following:
|
|
September 30, 2020
|
|
|
December 31, 2019
|
|
Income tax payable
|
|
$
|
1,035
|
|
|
$
|
692
|
|
Software license agreements liability
|
|
|
20,793
|
|
|
|
36,144
|
|
Operating lease liability
|
|
|
40,162
|
|
|
|
41,074
|
|
Others
|
|
|
2,950
|
|
|
|
1,007
|
|
|
|
$
|
64,940
|
|
|
$
|
78,917
|
|
12. Income Taxes
The Company normally determines its interim income tax provision using an estimated single annual effective tax rate for all tax jurisdictions. ASC 740 provides that when an entity operates in a jurisdiction that has generated ordinary losses on a year-to-date basis or on the basis of the results anticipated for the full fiscal year and no benefit can be recognized on those losses, a separate effective tax rate should be computed and applied to ordinary income (or loss) in that jurisdiction. The Company incurred pretax loss during the three and nine months ended September 30, 2020 and 2019 from its U.S. operations and will not recognize a tax benefit of the losses due to the full valuation allowance established against deferred tax assets. Thus, a separate effective tax rate was applied to losses from the U.S. jurisdiction to compute the Company’s September 30, 2020 and 2019 interim tax provision.
The Company recorded an income tax provision of $1,188 and $1,482 in the three and nine months ended September 30, 2020, respectively. The effective tax rates were (54.2%) and (3.2%) in the three and nine months ended September 30, 2020, respectively. The difference between the effective tax rates and the 21% federal statutory rate was primarily due to change in valuation allowance, foreign income taxes provided at lower rates, geographic mix in expected operating results, unrecognized tax benefits, recognition of federal and state research and development credits, windfall tax benefits from stock-based compensation and global intangible low-taxed income ("GILTI") inclusion. The income tax expense for the nine months ended September 30, 2020 included a reversal of certain unrecognized tax benefit as a result of the Internal Revenue Service exam conclusion with a no change report. The reversal of the unrecognized tax benefit had no impact on the Company’s income tax provision as a result of the full federal valuation allowance. The income tax expense for the nine months ended September 30, 2020 included an accrual for unrecognized tax benefit for foreign taxes and an income tax benefit for the remeasurement of certain net foreign deferred tax liability based on the renewed tax holiday period in Singapore.
The Company recorded an income tax provision of $619 and $1,252 in the three and nine months ended September 30, 2019, respectively. The effective tax rates were (4.0%) and (2.1%) in the three and nine months ended September 30, 2019, respectively. The difference between the effective tax rates and the 21% federal statutory rate was primarily due to change in valuation allowance, foreign income taxes provided at lower rates, geographic mix in expected operating results, unrecognized tax benefits, recognition of federal and state research and development credits, and windfall tax benefits from stock-based compensation.
Inphi Corporation
Notes to Unaudited Condensed Consolidated Financial Statements
(Dollars in thousands except share and per share amounts)
During the three and nine months ended September 30, 2020, the gross amount of the Company’s unrecognized tax benefits decreased approximately $1,203 and $4,856, respectively. The decrease for the three months ended September 30, 2020 was primarily a result of the remeasurement of certain foreign unrecognized tax benefits, partially offset by the results of tax positions taken during the current year. The decrease for the nine months ended September 30, 2020 was primarily a result of the Internal Revenue Service exam conclusion and the remeasurement of certain foreign unrecognized tax benefits, partially offset by the results of tax positions taken during the current year. Substantially all of the unrecognized tax benefits as of September 30, 2020, if recognized, would affect the Company’s effective tax rate.
The Company does not provide for U.S. income taxes on undistributed earnings of its controlled foreign corporations as the Company intends to reinvest these earnings indefinitely outside the U.S.
On March 27, 2020, the Coronavirus Aid, Relief and Economic Security Act (the “CARES Act”) was signed into law. The CARES Act includes measures concerning income tax, employer payroll taxes, and loan programs. The effect of the CARES Act is not expected to have a material impact on the Company’s consolidated financial statements and related disclosures.
13. Earnings Per Share
The following securities were not included in the computation of diluted earnings per share as inclusion would have been anti-dilutive:
|
|
Three Months Ended September 30,
|
|
|
Nine Months Ended September 30,
|
|
|
|
2020
|
|
|
2019
|
|
|
2020
|
|
|
2019
|
|
Common stock options
|
|
|
711,969
|
|
|
|
999,357
|
|
|
|
777,721
|
|
|
|
1,061,221
|
|
Unvested restricted stock units and market value stock units
|
|
|
2,758,458
|
|
|
|
2,781,820
|
|
|
|
2,872,917
|
|
|
|
2,787,656
|
|
Convertible debt
|
|
|
6,402,006
|
|
|
|
10,830,038
|
|
|
|
9,091,074
|
|
|
|
10,830,038
|
|
|
|
|
9,872,433
|
|
|
|
14,611,215
|
|
|
|
12,741,712
|
|
|
|
14,678,915
|
|
14. Stock–Based Compensation
In June 2010, the Company's Board of Directors (the “Board”) adopted the Company’s 2010 Stock Incentive Plan, which was amended and restated in July 2017 (the “2010 Plan”). The 2010 Plan provides for the grants of restricted stock, stock appreciation rights and stock unit awards to employees, non-employee directors, advisors and consultants. The compensation committee of the Board administers the 2010 Plan, including the determination of the recipient of an award, the number of shares subject to each award, whether an option is to be classified as an incentive stock option or nonstatutory option, and the terms and conditions of each award, including the exercise and purchase prices and the vesting or duration of the award. Options granted under the 2010 Plan are exercisable only upon vesting. At September 30, 2020, 5,695,657 shares of common stock have been reserved for future grants under the 2010 Plan.
Stock Option Awards
The Company did not grant any stock options during the three and nine months ended September 30, 2020 and 2019.
The following table summarizes information regarding options outstanding:
|
|
Number of Shares
|
|
|
Weighted Average Exercise Price
|
|
|
Weighted Average Remaining Contractual Life (Years)
|
|
|
Aggregate Intrinsic Value
|
|
Outstanding at December 31, 2019
|
|
|
905,141
|
|
|
$
|
13.68
|
|
|
|
1.81
|
|
|
$
|
54,616
|
|
Exercised
|
|
|
(207,424
|
)
|
|
$
|
10.53
|
|
|
|
|
|
|
|
|
|
Outstanding at September 30, 2020
|
|
|
697,717
|
|
|
$
|
14.62
|
|
|
|
1.29
|
|
|
$
|
68,120
|
|
Vested and Exercisable at September 30, 2020
|
|
|
697,717
|
|
|
$
|
14.62
|
|
|
|
1.29
|
|
|
$
|
68,120
|
|
The intrinsic value of options outstanding, exercisable and vested and expected to vest is calculated based on the difference between the exercise price and the fair value of the Company’s common stock as of the respective balance sheet dates.
Inphi Corporation
Notes to Unaudited Condensed Consolidated Financial Statements
(Dollars in thousands except share and per share amounts)
The total intrinsic value of options exercised during the nine months ended September 30, 2020 and 2019 was $17,326 and $7,953, respectively. The intrinsic value of exercised options is calculated based on the difference between the exercise price and the fair value of the Company’s common stock as of the exercise date. Cash received from the exercise of stock options was $2,177 and $1,907 for the nine months ended September 30, 2020 and 2019, respectively.
Restricted Stock Units
The Company granted restricted stock units (“RSUs”) to members of the Board and its employees. Most of the Company’s outstanding RSUs vest over four years with vesting contingent upon continuous service, and RSUs granted to non-employee directors after the initial grant vest on the first anniversary of the date of grant or immediately prior to the Company's next annual meeting of stockholders, if earlier. The Company estimates the fair value of RSUs using the market price of the common stock on the date of the grant. The fair value of these awards is amortized on a straight-line basis over the vesting period.
The following table summarizes information regarding outstanding RSUs:
|
|
Number of Shares
|
|
|
Weighted Average Grant Date Fair Value Per Share
|
|
Outstanding at December 31, 2019
|
|
|
3,822,325
|
|
|
$
|
41.38
|
|
Granted
|
|
|
1,426,180
|
|
|
$
|
87.74
|
|
Vested
|
|
|
(1,350,279
|
)
|
|
$
|
43.86
|
|
Canceled
|
|
|
(72,790
|
)
|
|
$
|
55.49
|
|
Outstanding at September 30, 2020
|
|
|
3,825,436
|
|
|
$
|
57.51
|
|
Expected to vest at September 30, 2020
|
|
|
3,786,642
|
|
|
|
|
|
The RSUs include performance-based stock units subject to achievement of pre-established revenue goal and earnings per share on a non-GAAP basis. Once the goals are met, the performance-based stock units are subject to four years of vesting from the original grant date, contingent upon continuous service. As of September 30, 2020, the total performance-based units outstanding was 39,338.
Market Value Stock Units
In February 2020, the compensation committee of the Board approved long-term market value stock unit (“MVSU”) awards to certain executive officers and employees, subject to certain market and service conditions, in the maximum total amount of 346,201 units. Recipients may earn between 0% to 225% of the target number of shares based on the Company’s achievement of total shareholder return (“TSR”) in comparison to the TSR of companies in the S&P 500 Index over a period of approximately two years and three years in length. The two-year and three-year MVSU grants will end on February 9, 2022 and 2023, respectively. If the Company’s absolute TSR is negative for the performance period, then the maximum number of shares that may be earned is the target number of shares. The fair value of the MVSU awards was estimated using a Monte Carlo simulation model and compensation is being recognized ratably over the service period. The expected volatility of the Company’s common stock was estimated based on the historical average volatility rate over the two- and three-year periods. The dividend yield assumption was based on historical and anticipated dividend payouts. The risk-free interest rate assumption was based on observed interest rates consistent with two- and three-year measurement periods. The total amount of compensation to recognize over the service period, and the assumptions used to value the grants are as follows:
|
|
Two-Year Term
|
|
|
Three-Year Term
|
|
Total target shares
|
|
|
53,448
|
|
|
|
101,775
|
|
Fair value per share
|
|
$
|
119.90
|
|
|
$
|
125.30
|
|
Total amount to be recognized over the service period
|
|
$
|
6,408
|
|
|
$
|
12,752
|
|
Risk free interest rate
|
|
|
1.41
|
%
|
|
|
1.38
|
%
|
Expected volatility
|
|
|
41.37
|
%
|
|
|
43.79
|
%
|
Dividend yield
|
|
|
—
|
|
|
|
—
|
|
Employee Stock Purchase Plan
In December 2011, the Board adopted the Company's Employee Stock Purchase Plan, which was amended and restated in April 2015, and further amended and restated in April 2018 (the “ESPP”). Participants purchase the Company's stock using payroll deductions, which may not exceed 15% of their total cash compensation. Pursuant to the terms of the ESPP, the "look-back" period for the stock purchase price is six months. Offering and purchase periods will begin on February 10 and August 10 of each year. Participants will be granted the right to purchase common stock at a price per share that is 85% of the lesser of the fair market value of the Company's common stock at the beginning or the end of each six-month period.
The ESPP imposes certain limitations upon an employee’s right to acquire common stock, including the following: (i) no employee shall be granted a right to participate if such employee would own stock possessing 5% or more of the total combined voting power or value of all classes of stock of the Company immediately after the election to purchase common stock, and (ii) no employee may be granted rights to purchase more than $25 of fair value of common stock in each calendar year. The maximum aggregate number of shares of common stock available for purchase under the ESPP is 2,750,000 shares. Total common stock issued under the ESPP during the nine months ended September 30, 2020 and 2019 was 128,892 and 208,721, respectively.
Inphi Corporation
Notes to Unaudited Condensed Consolidated Financial Statements
(Dollars in thousands except share and per share amounts)
The fair value of the ESPP purchases is estimated at the start of the offering period using the Black-Scholes option pricing model with the following assumptions:
|
|
Three Months Ended September 30,
|
|
|
Nine Months Ended September 30,
|
|
|
|
2020
|
|
|
2019
|
|
|
2020
|
|
|
2019
|
|
Risk-free interest rate
|
|
|
0.12
|
%
|
|
|
1.93
|
%
|
|
|
0.88
|
%
|
|
|
2.26
|
%
|
Expected life (in years)
|
|
|
0.50
|
|
|
|
0.50
|
|
|
|
0.49
|
|
|
|
0.49
|
|
Dividend yield
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
Expected volatility
|
|
|
62
|
%
|
|
|
39
|
%
|
|
|
50
|
%
|
|
|
43
|
%
|
Estimated fair value
|
|
$
|
38.02
|
|
|
$
|
16.50
|
|
|
$
|
29.17
|
|
|
$
|
13.35
|
|
Stock-Based Compensation Expense
Stock-based compensation expense is included in the Company’s condensed consolidated statements of income (loss) as follows:
|
|
Three Months Ended September 30,
|
|
|
Nine Months Ended September 30,
|
|
|
|
2020
|
|
|
2019
|
|
|
2020
|
|
|
2019
|
|
Cost of goods sold
|
|
$
|
2,136
|
|
|
$
|
1,953
|
|
|
$
|
6,033
|
|
|
$
|
4,432
|
|
Research and development
|
|
|
16,484
|
|
|
|
10,297
|
|
|
|
45,995
|
|
|
|
30,954
|
|
Sales and marketing
|
|
|
5,858
|
|
|
|
4,312
|
|
|
|
16,320
|
|
|
|
11,729
|
|
General and administrative
|
|
|
4,568
|
|
|
|
3,316
|
|
|
|
12,953
|
|
|
|
9,482
|
|
|
|
$
|
29,046
|
|
|
$
|
19,878
|
|
|
$
|
81,301
|
|
|
$
|
56,597
|
|
Total unrecognized compensation cost related to unvested restricted stock units at September 30, 2020, prior to the consideration of expected forfeitures, is approximately $185,745 and is expected to be recognized over a weighted-average period of 2.64 years.
15. Fair Value Measurements
The guidance on fair value measurements requires fair value measurements to be classified and disclosed in one of the following three categories:
Level 1: Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities;
Level 2: Quoted prices in markets that are not active, or inputs which are observable, either directly or indirectly, for substantially the full term of the asset or liability; or
Level 3: Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (i.e., supported by little or no market activity).
The Company measures its investments in marketable securities at fair value using the market approach, which uses prices and other relevant information generated by market transactions involving identical or comparable assets or liabilities. The Company has cash equivalents which consist of money market funds valued using the amortized cost method, in accordance with Rule 2a-7 under the 1940 Act which approximates fair value.
The Convertible Notes are carried on the condensed consolidated balance sheets at their original issuance value including accreted interest, net of unamortized debt discount and issuance cost. The Convertible Notes are not marked to fair value at the end of each reporting period. As of September 30, 2020 and December 31, 2019, the fair value of the Convertible Notes was determined on the basis of market prices observable for similar instruments and is considered Level 2 in the fair value hierarchy. The fair value of the outstanding Convertible Notes as of September 30, 2020 and December 31, 2019 was $873,967 and $845,296, respectively.
Inphi Corporation
Notes to Unaudited Condensed Consolidated Financial Statements
(Dollars in thousands except share and per share amounts)
The following table presents information about assets and liabilities required to be carried at fair value on a recurring basis:
September 30, 2020
|
|
Total
|
|
|
Level 1
|
|
|
Level 2
|
|
Assets
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash equivalents:
|
|
|
|
|
|
|
|
|
|
|
|
|
Money market funds
|
|
$
|
10,640
|
|
|
$
|
10,004
|
|
|
$
|
636
|
|
Commercial paper
|
|
|
17,028
|
|
|
|
—
|
|
|
|
17,028
|
|
Investment in marketable debt securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
Municipal bonds
|
|
|
19,093
|
|
|
|
—
|
|
|
|
19,093
|
|
Corporate notes/bonds
|
|
|
49,925
|
|
|
|
—
|
|
|
|
49,925
|
|
Asset backed securities
|
|
|
2,520
|
|
|
|
—
|
|
|
|
2,520
|
|
Commercial paper
|
|
|
3,539
|
|
|
|
—
|
|
|
|
3,539
|
|
|
|
$
|
102,745
|
|
|
$
|
10,004
|
|
|
$
|
92,741
|
|
December 31, 2019
|
|
Total
|
|
|
Level 1
|
|
|
Level 2
|
|
Assets
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash equivalents:
|
|
|
|
|
|
|
|
|
|
|
|
|
Money market funds
|
|
$
|
190,598
|
|
|
$
|
67,494
|
|
|
$
|
123,104
|
|
Commercial paper
|
|
|
9,465
|
|
|
|
—
|
|
|
|
9,465
|
|
Municipal bonds
|
|
|
1,250
|
|
|
|
—
|
|
|
|
1,250
|
|
Investments in marketable securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. Treasury securities
|
|
|
3,759
|
|
|
|
3,759
|
|
|
|
—
|
|
Municipal bonds
|
|
|
6,119
|
|
|
|
—
|
|
|
|
6,119
|
|
Corporate notes/bonds
|
|
|
119,449
|
|
|
|
—
|
|
|
|
119,449
|
|
Asset-backed securities
|
|
|
4,268
|
|
|
|
—
|
|
|
|
4,268
|
|
Commercial paper
|
|
|
6,464
|
|
|
|
—
|
|
|
|
6,464
|
|
Certificate of deposit
|
|
|
72
|
|
|
|
72
|
|
|
|
—
|
|
|
|
$
|
341,444
|
|
|
$
|
71,325
|
|
|
$
|
270,119
|
|
As discussed in note 4, the Company has a marketable equity investment. The marketable equity investment is classified as Level 1 in the fair value hierarchy. As discussed in note 4, the Company has non-marketable equity investments, which are classified within Level 3 in the fair value hierarchy because the Company estimates the value based on valuation methods using the observable transaction price at the most recent transaction date.
16. Segment and Geographic Information
The Company operates in one reportable segment. The Company’s Chief Executive Officer, who is considered to be the chief operating decision maker, manages the Company’s operations as a whole and reviews consolidated financial information for purposes of evaluating financial performance and allocating resources. Revenue by region is classified based on the locations to which the products are shipped, which may differ from the customer’s principal offices.
The following table sets forth the Company’s revenue by geographic region:
|
|
Three Months Ended September 30,
|
|
|
Nine Months Ended September 30,
|
|
|
|
2020
|
|
|
2019
|
|
|
2020
|
|
|
2019
|
|
China
|
|
$
|
102,391
|
|
|
$
|
34,503
|
|
|
$
|
272,251
|
|
|
$
|
110,769
|
|
United States
|
|
|
37,446
|
|
|
|
32,936
|
|
|
|
112,527
|
|
|
|
73,902
|
|
Thailand
|
|
|
21,286
|
|
|
|
14,816
|
|
|
|
54,017
|
|
|
|
41,661
|
|
Other
|
|
|
19,568
|
|
|
|
11,976
|
|
|
|
56,618
|
|
|
|
36,407
|
|
|
|
$
|
180,691
|
|
|
$
|
94,231
|
|
|
$
|
495,413
|
|
|
$
|
262,739
|
|
Inphi Corporation
Notes to Unaudited Condensed Consolidated Financial Statements
(Dollars in thousands except share and per share amounts)
As of September 30, 2020, $65,765 of long-lived tangible assets are located outside the United States, of which $55,910 are located in Taiwan. As of December 31, 2019, $33,826 of long-lived tangible assets are located outside the United States, of which $27,750 are located in Taiwan.
17. Commitments and Contingencies
Noncancelable Purchase Obligations
The Company has noncancelable service agreements, including software licenses, colocation and cloud services used in research and development activities expiring in various years through 2024. As of September 30, 2020, future minimum payments under the noncancelable agreements are as follows:
2020 (remaining)
|
|
$
|
243
|
|
2021
|
|
|
720
|
|
2022
|
|
|
69
|
|
2023
|
|
|
4
|
|
2024
|
|
|
2
|
|
Total
|
|
$
|
1,038
|
|
The Company depends upon third-party subcontractors to manufacture its wafers. The Company’s subcontractor relationships typically allow for the cancellation of outstanding purchase orders, but require payment of all expenses incurred through the date of cancellation. As of September 30, 2020, the total value of open purchase orders for wafers was approximately $39,308.
Legal Proceedings
Netlist, Inc. v. Inphi Corporation, Case No. 09-cv-6900 (C.D. Cal.)
On September 22, 2009, Netlist filed suit in the United States District Court, Central District of California (the “Court”), asserting that the Company infringes U.S. Patent No. 7,532,537. Netlist filed an amended complaint on December 22, 2009, further asserting that the Company infringes U.S. Patent Nos. 7,619,912 and 7,636,274, collectively with U.S. Patent No. 7,532,537, the patents-in-suit, and seeking both unspecified monetary damages to be determined and an injunction to prevent further infringement. These infringement claims allege that the iMB™ and certain other memory module components infringe the patents-in-suit. The Company answered the amended complaint on February 11, 2010 and asserted that the Company does not infringe the patents-in-suit and that the patents-in-suit are invalid. In 2010, the Company filed inter partes requests for reexamination with the United States Patent and Trademark Office (the “USPTO”), asserting that the patents-in-suit are invalid. As a result of the proceedings at the USPTO, the Court has stayed the litigation, with the parties advising the Court on status every 120 days.
As to the proceeding at the USPTO, reexamination has been ordered for all of the patents that Netlist alleged to infringe. At present, the USPTO has determined that almost all of the originally filed claims are not valid, and determined certain amended claims to be patentable. The Reexamination Certificate for U.S. Patent No. 7,532,537 was issued on August 2, 2016 based on amended claims. The Reexamination Certificate for U.S. Patent No. 7,636,274 was issued on November 5, 2018, indicating that all claims, 1 through 97, were cancelled. The Court of Appeals for the Federal Circuit decided the appeals of various parties, and affirmed the decision of the Patent Trial and Appeal Board on June 15, 2020 with respect to the reexamination proceeding for U.S. Patent No. 7,619,912. The Patent Office is expected to proceed in a manner that is consistent with the decision of the Court of Appeals for the Federal Circuit.
While the Company intends to defend the lawsuit vigorously, in view of the USPTO and Federal Circuit proceedings, whether or not determined in the Company’s favor or settled, the lawsuit could be costly and time-consuming and could divert management’s attention and resources, which could adversely affect the Company’s business.
Due to the nature of litigation, the Company is currently unable to predict the final outcome of this lawsuit and therefore cannot determine the likelihood of loss nor estimate a range of possible loss. However, because of the nature and inherent uncertainties of litigation, should the outcome of these actions be unfavorable, the Company’s business, financial condition, results of operations or cash flows could be materially and adversely affected.
Inphi Corporation
Notes to Unaudited Condensed Consolidated Financial Statements
(Dollars in thousands except share and per share amounts)
Claims Against eSilicon
In connection with the Company's acquisition of eSilicon, eSilicon and the Company have received written communications from certain former stockholders of eSilicon demanding to inspect eSilicon’s books and records and indicating that such stockholders will be seeking appraisal of shares they held in eSilicon. Certain of these former eSilicon stockholders also have stated that they may assert claims against eSilicon’s directors and senior officers for alleged breaches of fiduciary duty and other violations in connection with the merger between eSilicon and a subsidiary of the Company. The Company is unaware of any petition for appraisal and/or lawsuit being filed by any former eSilicon stockholder. The Company believes that the claims in such written communications are without merit, and plan to vigorously defend against lawsuits arising out of or relating to the merger agreement and/or the merger that may be filed in the future.
Indemnifications
In the ordinary course of business, the Company may provide indemnifications of varying scope and terms to customers, vendors, lessors, investors, directors, officers, employees and other parties with respect to certain matters, including, but not limited to, losses arising out of the Company’s breach of such agreements, services to be provided by the Company, or from intellectual property infringement claims made by third-parties. These indemnifications may survive termination of the underlying agreement and the maximum potential amount of future payments the Company could be required to make under these indemnification provisions may not be subject to maximum loss clauses. The Company has not incurred material costs to defend lawsuits or settle claims related to these indemnifications. Accordingly, the Company has no liabilities recorded for these agreements as of September 30, 2020 and December 31, 2019.
18. Subsequent Events
Pending Merger with Marvell Technology
On October 29, 2020, the Company entered into an Agreement and Plan of Merger and Reorganization (the “Merger Agreement”) with Marvell Technology Group Ltd., a Bermuda exempted company (“Marvell”), Maui HoldCo, Inc., a Delaware corporation and a wholly-owned subsidiary of Marvell (“HoldCo”), Maui Acquisition Company Ltd, a Bermuda exempted company and a wholly-owned subsidiary of HoldCo (“Bermuda Merger Sub”), and Indigo Acquisition Corp., a Delaware corporation and a wholly-owned subsidiary of HoldCo (“Delaware Merger Sub”), pursuant to which, subject to the terms and conditions of the Merger Agreement, Bermuda Merger Sub will merge with and into Marvell, with Marvell surviving the merger as a wholly-owned subsidiary of HoldCo (the “Bermuda Merger”), followed immediately by the merger of Delaware Merger Sub with and into the Company, with the Company surviving the merger as a wholly-owned subsidiary of HoldCo (the “Delaware Merger” and, together with the Bermuda Merger, the “Mergers”). The Mergers will result in a combined company domiciled in the United States, with Marvell shareholders owning approximately 83% of the combined company, and the Company’s stockholders owning approximately 17% of the combined company.
Pursuant to the Merger Agreement, and upon the terms and subject to the conditions described therein, (i) at the effective time of the Bermuda Merger, all issued and outstanding common shares of Marvell (other than shares held by Marvell in Marvell’s treasury or held by HoldCo, Bermuda Merger Sub or any other subsidiary of Marvell) will be automatically converted into the right to receive one share of common stock of HoldCo (“HoldCo Common Stock”) and (ii) at the effective time of the Delaware Merger, all outstanding shares of common stock of the Company (other than (x) shares held by the Company (or held in the Company’s treasury) or held by Marvell, Delaware Merger Sub or any other subsidiary of Marvell or held, directly or indirectly, by any subsidiary of the Company or (y) shares with respect to which appraisal rights are properly exercised and not withdrawn under Delaware law) will be automatically converted into the right to receive 2.323 shares of HoldCo Common Stock and $66.0 in cash per share, without interest, plus cash in lieu of any fractional shares of HoldCo Common Stock.
If the Merger Agreement is terminated under certain circumstances, an alternative acquisition proposal had previously been made with respect to the Company, and within 12 months of the termination of the Merger Agreement, the Company enters into a definitive agreement for certain extraordinary corporate transactions or completes any such transaction, the Company would be obligated to pay Marvell a fee equal to $300,000. The Company would also be obligated to pay this fee if the Merger Agreement is terminated because of certain triggering events by the Company, including the Board changing or withdrawing its recommendation regarding the Mergers, or failing to reaffirm its’ support for the Mergers in certain circumstances. Additionally, the Company would be obligated to pay this fee if it elects to terminate the Merger Agreement to enter into certain superior acquisition transactions.
If the Merger Agreement is terminated because of certain triggering events by Marvell, including Marvell’s board of directors changing or withdrawing its recommendation regarding the Mergers, or failing to reaffirm its support for the Mergers in certain circumstances, Marvell would be obligated to pay the Company a fee equal to $400,000. Marvell would also be obligated to pay this fee if it elects to terminate the Merger Agreement to enter into certain superior acquisition transactions. Additionally, if the Merger Agreement is terminated due to failure to receive certain regulatory approvals or because of the existence of certain government orders or litigations, Marvell would be obligated to pay the Company a fee equal to $460,000.
If the Merger Agreement is terminated due to the failure to obtain the Company’s stockholder approval or Marvell’s shareholder approval, the party whose stockholders did not approve the transaction will be obligated to reimburse the other party for its fees, costs and other expenses related to the Merger Agreement (including legal fees, financial advisory fees, and consultant fees), up to a maximum of $25,000.
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
The following discussion of our financial condition and results of operations should be read in conjunction with the condensed consolidated financial statements and notes to those statements included elsewhere in this Quarterly Report. This Management’s Discussion and Analysis of Financial Condition and Results of Operations and this report contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. When used in this report, the terms “may,” “will,” “intend,” “should,” “could,” “can,” “would,” “expect,” “believe,” “estimate,” “predict,” “potential,” “plan,” “anticipate,” “seek,” “future,” “strategy,” “likely,” or the negative of these terms, and similar expressions are intended to identify forward-looking statements. These statements include statements regarding the potential benefits of the proposed acquisition by Marvell of us, including future financial and operating results, plans, objectives, expectations and intentions, the impact of the COVID-19 pandemic (including any changes in laws or regulations in reaction to same) on our personnel, on our suppliers, and on our customers and their respective end markets, our anticipated trends and challenges in our business and the markets in which we operate, including the market for 25G to 600G high-speed analog semiconductor solutions, our competitive position, demand for our current products, our plans for future products and anticipated features and benefits thereof, expansion of our product offerings and business activities, our plans to expand international operations, enhancements of existing products, the benefits of outsourcing, our ability to forecast demand and its effects, the impact of U.S. government export restrictions on Huawei, our acquisitions and investments in other companies or technologies, including our acquisitions of eSilicon Corporation and Arrive Technologies, Inc. and the anticipated benefits thereof, critical accounting policies and estimates, our expectations regarding our expenses and revenue, sources of revenue, our effective tax rate and tax benefits, the benefits of our products and services, our technological capabilities and expertise, our liquidity position and sufficiency thereof, including our anticipated cash needs and uses of cash, our ability to generate cash, our operating and capital expenditures and requirements and our needs for additional financing and potential consequences thereof, expectations regarding settlement of convertible notes, repatriation of cash balances from our foreign subsidiaries, our contractual obligations, our anticipated growth and growth strategies, including growing our end customer base, interest rate sensitivity, adequacy of our disclosure controls, and our legal proceedings and warranty claims. These forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by these or any other forward-looking statements. These risks and uncertainties include, but are not limited to, risks related to the satisfaction of the conditions to closing the acquisition by Marvell of us (including the failure to obtain necessary regulatory and stockholder approvals) in the anticipated timeframe or at all, risks related to the ability to realize the anticipated benefits of the acquisition, including the possibility that the expected benefits to the combined company from the proposed acquisition will not be realized or will not be realized within the expected time period, disruption from the transaction making it more difficult to maintain business, contractual and operational relationships, the unfavorable outcome of any legal proceedings that have been or may be instituted against Marvell, us or the combined company, the ability to retain key personnel, negative effects of this announcement or the consummation of the proposed acquisition on the market price of the capital stock of us or Marvell, and on our and Marvell’s operating results, risks relating to the value of the HoldCo Common Stock to be issued in the transaction, significant transaction costs, fees, expenses and charges, unknown liabilities, the risk of litigation and/or regulatory actions related to the proposed acquisition, the occurrence of any event, change or other circumstances that could give rise to the termination of the merger agreement, the impact of the COVID-19 pandemic, factors affecting our results of operations, our ability to manage our growth, our ability to sustain or increase profitability, demand for our solutions, the effect of changes in average selling prices for our products, our ability to compete, our ability to rapidly develop new technology and introduce new products, our ability to safeguard our intellectual property, our ability to qualify for tax holidays and incentives, trends in the semiconductor industry and fluctuations in general economic conditions, the risks set forth throughout this report, including the risks set forth under Part II, “Item 1A. Risk Factors” and the risks set forth from time to time in our filings with the Securities and Exchange Commission, including its Annual Report on Form 10-K for the year ended December 31, 2019. Readers are cautioned not to place undue reliance on these forward-looking statements, which are based on current expectations and reflect management's opinions only as of the date hereof. These forward-looking statements speak only as of the date of this report. We do not intend to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in our expectations with regard thereto or any changes in events, conditions or circumstances on which any such statement is based, unless otherwise required by law.
All references to “Inphi,” “we,” “us” or “our” mean Inphi Corporation.
Inphi®, iKON™, InphiNityCore™, Canopus™, ColorZ®, ColorZ-Lite™, iMB™, OmniConnect™, Polaris™, Tri-rate®, Vega™, M200 LightSpeed-III™, Porrima™ and the Inphi logo are among the trademarks, registered trademarks, or service marks owned by Inphi.
Overview
COVID-19
In March 2020, the World Health Organization declared the COVID-19 outbreak a pandemic, and the virus continues to spread in areas where we operate and sell our products and services. Several public health organizations have recommended, and many local governments have implemented, certain measures to slow and limit the transmission of the virus, including shelter in place and social distancing ordinances, which has resulted in a significant deterioration of economic conditions in many of the countries in which we operate.
The impact of COVID-19 and the related disruptions caused to the global economy and our business did not have a material adverse impact on our business during the nine months ended September 30, 2020. During the nine months ended September 30, 2020, COVID-19 had a significant impact on the global economy, including accelerating the shift to cloud computing and driving a sharp increase in demand for bandwidth. Our operating results for the three and nine months ended September 30, 2020 were not significantly affected by the COVID-19 pandemic. However, the spread of the COVID-19 virus caused us to modify our business practices, including implementing work-from-home policies and restricting travel by our employees. We also took certain actions in response to the pandemic, which are set forth above in “Note Regarding COVID-19.”
Looking forward, we believe that our business will continue to be favorably impacted by the increased demand for bandwidth caused by the impact of the COVID-19 pandemic, however, given the dynamic nature of COVID-19, we have considered its impact when developing our estimates and assumptions. Actual results and outcomes may differ from our estimates and assumptions. Additionally, while the impact of the pandemic may increase demand for our products either in the short-term or in the long-term, it may also adversely affect our ability to meet that demand, as measures taken in response to the pandemic may affect the operations of our suppliers and customers, as their own workforces are disrupted. As a result, our supply chain may be interrupted and we may experience delays in the delivery of our product. The impact of the pandemic on the global economy and on our business, as well as on the business of our suppliers and customers, and the additional measures that may be needed in the future in response to it, will depend on many factors beyond our control and knowledge. We will monitor the situation to determine what actions may be necessary or appropriate to address the impact of the pandemic, which may include actions mandated or recommended by federal, state or local authorities.
Our Company
We are a fabless provider of high-speed analog and mixed signal semiconductor solutions for the communications and cloud markets. Our analog and mixed signal semiconductor solutions provide high signal integrity at leading-edge data speeds while reducing system power consumption. Our semiconductor solutions are designed to address bandwidth bottlenecks in networks, maximize throughput and minimize latency in computing environments and enable the rollout of next generation communications and cloud infrastructures. Our solutions provide a vital high-speed interface between analog and mixed signals and digital information in high-performance systems such as telecommunications transport systems, enterprise networking equipment and data centers. We provide 25G to 600G high-speed analog and mixed signal semiconductor solutions for the communications market.
In January 2020, we completed the acquisition of eSilicon Corporation (“eSilicon”) for approximately $214.6 million. A portion of the consideration has been placed in an escrow fund for up to 12 months (or up to 36 months in certain circumstances) following the closing for the satisfaction of certain indemnification obligations. We acquired eSilicon to accelerate our roadmap in developing electro-optics solutions for cloud and telecommunications customers.
In May 2020, we purchased certain assets and rights of Arrive Technologies, Inc. ("Arrive") for approximately $20.1 million. A portion of the consideration was withheld for 12 months following the closing for the satisfaction of certain potential indemnification claims. We acquired Arrive for the expansion of our presence into strategic geographic regions for talent acquisition.
In April 2020, we issued $506.0 million aggregate principal amount of our 0.75% Convertible Senior Notes due 2025 in a private placement. We also repurchased some of our Convertible Notes 2015 and Convertible Notes 2016 during the nine months ended September 30, 2020.
A detailed discussion of our business may be found in Part I, “Item 1. Business.” of our Annual Report on Form 10-K for the year ended December 31, 2019.
Quarterly Update
As discussed in more detail below, for the three and nine months ended September 30, 2020 compared to the three and nine months ended September 30, 2019, we delivered the following financial performance:
|
•
|
Revenue increased by $86.5 million, or 92%, to $180.7 million in the three months ended September 30, 2020. In the nine months ended September 30, 2020, revenue increased by $232.7 million, or 89%, to $495.4 million.
|
|
|
|
|
•
|
Gross profit as a percentage of revenue decreased from 58% to 56% in the three months ended September 30, 2020. In the nine months ended September 30, 2020, gross profit as a percentage of revenue decreased from 58% to 54%.
|
|
|
|
|
•
|
Total operating expenses increased by $29.9 million, or 46%, to $95.3 million in the three months ended September 30, 2020. In the nine months ended September 30, 2020, total operating expenses increased by $90.7 million, or 47%, to $282.5 million.
|
|
•
|
Loss from operations decreased by $17.1 million to income from operations of $6.2 million in the three months ended September 30, 2020. In the nine months ended September 30, 2020, loss from operations decreased by $26.3 million to $14.3 million.
|
|
•
|
During the nine months ended September 30, 2020, we repurchased and converted some of our Convertible Notes 2015 and Convertible Notes 2016 which resulted in a loss on early extinguishment of $13.4 million.
|
|
•
|
Loss per share decreased to $0.07 from $0.36 in the three months ended September 30, 2020. In the nine months ended September 30, 2020, loss per share decreased to $0.97 from $1.32.
|
The increase in our revenue for the three months and nine months ended September 30, 2020 was primarily the result of increases in telecommunication, cloud and legacy products, including eSilicon products.
The decrease in gross profit as a percentage of revenue in the three and nine months ended September 30, 2020 was due to amortization of inventory fair value step-up of acquired inventories and amortization of acquired intangibles related to the eSilicon acquisition and change in product and revenue mix.
Total operating expenses for the three and nine months ended September 30, 2020 increased year-over-year primarily due to an increase in headcount and stock-based compensation expense as a result of new equity grants. Our expenses primarily consist of personnel costs, which include compensation, benefits, payroll related taxes and stock-based compensation. From July 2019 to September 2020, our headcount increased by 102 new employees, primarily in the engineering department. In addition, the acquisitions of eSilicon and Arrive added 318 employees, including transition employees. We expect expenses to continue to increase in absolute dollars as we continue to invest resources to develop more products and to support the growth of our business. Our loss per share for the three months ended September 30, 2020 decreased primarily due to higher gross profit, partially offset by higher operating expenses and lower interest income and unrealized gain on equity investment. Our loss per share for the nine months ended September 30, 2020 decreased primarily due to higher gross profit, partially offset by higher operating expenses and loss on early extinguishment of debt.
Our cash and cash equivalents were $147.9 million at September 30, 2020, compared with $282.7 million at December 31, 2019. Cash provided by operating activities was $110.9 million during the nine months ended September 30, 2020 compared to $75.0 million during the nine months ended September 30, 2019. Cash used in investing activities during the nine months ended September 30, 2020 was $202.5 million due to the acquisitions of business of $223.7 million, purchases of property and equipment of $52.5 million, marketable securities of $41.9 million, and equity investment of $6.0 million, partially offset by maturities and sales of marketable securities of $107.3 million, and proceeds from the eSilicon investment of $15.0 million. Cash used in financing activities during the nine months ended September 30, 2020 was $43.3 million primarily due to convertible debt repurchases of $410.0 million, payments of obligations relating to purchase of intangible assets of $31.0 million, minimum tax withholding paid on behalf of employees for net share settlement of $49.2 million, purchase of capped call options of $55.7 million, and payments of obligations relating to equipment financing of $0.3 million, partially offset by proceeds from convertible debt, net of cost of $492.7 million, proceeds from ESPP purchases and exercise of stock options of $10.1 million.
Recent Development
On October 29, 2020, we entered into an Agreement and Plan of Merger and Reorganization (the “Merger Agreement”) with Marvell Technology Group Ltd., a Bermuda exempted company (“Marvell”), Maui HoldCo, Inc., a Delaware corporation and a wholly-owned subsidiary of Marvell (“HoldCo”), Maui Acquisition Company Ltd, a Bermuda exempted company and a wholly-owned subsidiary of HoldCo (“Bermuda Merger Sub”), and Indigo Acquisition Corp., a Delaware corporation and a wholly-owned subsidiary of HoldCo (“Delaware Merger Sub”), pursuant to which, subject to the terms and conditions of the Merger Agreement, Bermuda Merger Sub will merge with and into Marvell, with Marvell surviving the merger as a wholly-owned subsidiary of HoldCo (the “Bermuda Merger”), followed immediately by the merger of Delaware Merger Sub with and into Inphi, with Inphi surviving the merger as a wholly-owned subsidiary of HoldCo (the “Delaware Merger” and, together with the Bermuda Merger, the “Mergers”). The Mergers will result in a combined company domiciled in the United States, with Marvell shareholders owning approximately 83% of the combined company, and our stockholders owning approximately 17% of the combined company.
Pursuant to the Merger Agreement, and upon the terms and subject to the conditions described therein, (i) at the effective time of the Bermuda Merger, all issued and outstanding common shares of Marvell (other than shares held by Marvell in Marvell’s treasury or held by HoldCo, Bermuda Merger Sub or any other subsidiary of Marvell) will be automatically converted into the right to receive one share of common stock of HoldCo (“HoldCo Common Stock”) and (ii) at the effective time of the Delaware Merger, all outstanding shares of our common stock (other than (x) shares held by us (or held in our treasury) or held by Marvell, Delaware Merger Sub or any other subsidiary of Marvell or held, directly or indirectly, by any of our subsidiaries or (y) shares with respect to which appraisal rights are properly exercised and not withdrawn under Delaware law) will be automatically converted into the right to receive 2.323 shares of HoldCo Common Stock and $66.0 in cash per share, without interest, plus cash in lieu of any fractional shares of HoldCo Common Stock.
The Merger Agreement contains customary representations and warranties of Marvell and us relating to their and our respective businesses and public filings, in each case generally subject to a materiality and “Material Adverse Effect” qualifiers. Additionally, the Merger Agreement provides for customary pre-closing covenants of us, including a covenant to conduct its business in the ordinary course in all material respects and in accordance with past practice and to refrain from taking certain actions without Marvell’s consent. We have agreed not to solicit proposals, provide information to third parties, or enter into discussions, relating to alternative transaction proposals, or recommend or enter into agreements relating to certain specified alternative transactions, subject, to certain exceptions that would permit us to consider and recommend certain superior proposals if the failure to do so would be inconsistent with our board of directors’ fiduciary duties, or to terminate the Merger Agreement to accept certain superior proposals if the failure to do so would be inconsistent with our board of directors fiduciary duties.
Consummation of the Mergers is subject to various conditions, including, among others, (a) adoption of the Merger Agreement by our stockholders; (b) the approval of the Bermuda Merger by Marvell’s shareholders; (c) the effectiveness of a registration statement on Form S-4 to be filed with the SEC by HoldCo in connection with the issuance of HoldCo Common Stock in the Mergers; (d) the approval of the listing of HoldCo Common Stock on The Nasdaq Stock Market LLC; and (e) the expiration of the applicable waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, and certain other regulatory clearances. The obligation of each party to consummate the Mergers is also conditioned upon the other party’s representations and warranties being true and correct (subject to certain materiality exceptions), the other party having performed in all material respects its covenants and obligations under the Merger Agreement and the absence of a “Material Adverse Effect” on the other party (as defined in the Merger Agreement).
The Merger Agreement also provides the parties with rights to terminate the Merger Agreement in certain circumstances, including if the Mergers have not been consummated by June 29, 2021 (which may be extended up to March 1, 2022 in order to satisfy certain regulatory closing conditions), if either party fails to obtain the necessary approvals for the Mergers from its stockholders, or if there is an order permanently restraining, enjoining, or otherwise prohibiting either Merger.
If the Merger Agreement is terminated under certain circumstances, an alternative acquisition proposal had previously been made with respect to us, and within 12 months of the termination of the Merger Agreement, we enter into a definitive agreement for certain extraordinary corporate transactions or completes any such transaction, we would be obligated to pay Marvell a fee equal to $300.0 million. We would also be obligated to pay this fee if the Merger Agreement is terminated because of certain triggering events by us, including our board of directors changing or withdrawing its recommendation regarding the Mergers, or failing to reaffirm its’ support for the Mergers in certain circumstances. Additionally, we would be obligated to pay this fee if we elect to terminate the Merger Agreement to enter into certain superior acquisition transactions.
If the Merger Agreement is terminated because of certain triggering events by Marvell, including Marvell’s board of directors changing or withdrawing its recommendation regarding the Mergers, or failing to reaffirm its support for the Mergers in certain circumstances, Marvell would be obligated to pay us a fee equal to $400.0 million. Marvell would also be obligated to pay this fee if it elects to terminate the Merger Agreement to enter into certain superior acquisition transactions. Additionally, if the Merger Agreement is terminated due to failure to receive certain regulatory approvals or because of the existence of certain government orders or litigations, Marvell would be obligated to pay us a fee equal to $460.0 million.
If the Merger Agreement is terminated due to the failure to obtain our stockholder approval or Marvell’s shareholder approval, the party whose stockholders did not approve the transaction will be obligated to reimburse the other party for its fees, costs and other expenses related to the Merger Agreement (including legal fees, financial advisory fees, and consultant fees), up to a maximum of $25.0 million.
In connection with the Mergers, Marvell delivered to us a copy of (i) an executed 364-day bridge facility commitment letter, dated as of October 29, 2020, among Marvell, HoldCo and JPMorgan Chase Bank, N.A. (“JPMorgan”) and (ii) an executed facilities commitment letter, dated as of October 29, 2020, among Marvell, HoldCo and JPMorgan, pursuant to which JPMorgan has committed, subject to customary conditions, to lend initially to Marvell and on and after the closing date of the Mergers, HoldCo, up to $4,000.0 million of bridge and term loans for the purpose of funding the Mergers on the closing date (the “Debt Financing”). Marvell’s obligations pursuant to the Merger Agreement are not conditioned on Marvell obtaining the Debt Financing.
Critical Accounting Policies and Estimates
The preparation of financial statements in accordance with U.S. generally accepted accounting principles, or GAAP, requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of net revenue and expenses in the reporting period. We regularly evaluate our estimates and assumptions related to credit losses, warranty reserves, inventory reserves, stock-based compensation expense, goodwill and intangible assets valuation, allowance for distributors’ price discounts, valuation of equity securities, recognition and disclosure of fair value of convertible debt, deferred income tax asset valuation allowances, uncertain tax positions, litigation, other loss contingencies and business combinations. We base our estimates and assumptions on current facts, historical experience and various other factors that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the recording of revenue, costs and expenses that are not readily apparent from other sources. In March 2020, the outbreak of COVID-19 was declared a pandemic by the World Health Organization. While the nature of the situation is dynamic, the Company has considered the impact when developing its estimates and assumptions noted above. The actual results experienced by us may differ materially and adversely from our estimates. To the extent there are material differences between our estimates and the actual results, our future results of operations will be affected. For a description of our critical accounting policies and estimates, please refer to the “Critical Accounting Policies and Estimates” section of our Management’s Discussion and Analysis of Financial Condition and Results of Operations contained in our Annual Report on Form 10-K for the year ended December 31, 2019. There have been no material changes in any of our critical accounting policies during the nine months ended September 30, 2020. On January 1, 2020, we adopted ASU 2016-13, Credit Losses (Topic 326). The effects of this adoption are discussed in note 2 of the Notes to Unaudited Condensed Consolidated Financial Statements.
Results of Operations
The following table sets forth a summary of our statements of income (loss) as a percentage of each line item to the revenue:
|
|
Three Months Ended September 30,
|
|
|
Nine Months Ended September 30,
|
|
|
|
2020
|
|
|
2019
|
|
|
2020
|
|
|
2019
|
|
Revenue
|
|
|
100
|
%
|
|
|
100
|
%
|
|
|
100
|
%
|
|
|
100
|
%
|
Cost of revenue
|
|
|
44
|
|
|
|
42
|
|
|
|
46
|
|
|
|
42
|
|
Gross profit
|
|
|
56
|
|
|
|
58
|
|
|
|
54
|
|
|
|
58
|
|
Operating expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Research and development
|
|
|
37
|
|
|
|
47
|
|
|
|
40
|
|
|
|
51
|
|
Sales and marketing
|
|
|
9
|
|
|
|
13
|
|
|
|
9
|
|
|
|
13
|
|
General and administrative
|
|
|
7
|
|
|
|
9
|
|
|
|
8
|
|
|
|
9
|
|
Total operating expenses
|
|
|
53
|
|
|
|
69
|
|
|
|
57
|
|
|
|
73
|
|
Income (loss) from operations
|
|
|
3
|
|
|
|
(11
|
)
|
|
|
(3
|
)
|
|
|
(15
|
)
|
Interest expense
|
|
|
(5
|
)
|
|
|
(10
|
)
|
|
|
(6
|
)
|
|
|
(10
|
)
|
Loss on early extinguishment of debt
|
|
|
—
|
|
|
|
—
|
|
|
|
(3
|
)
|
|
|
—
|
|
Other income (expense), net
|
|
|
—
|
|
|
|
5
|
|
|
|
2
|
|
|
|
3
|
|
Loss before income taxes
|
|
|
(2
|
)
|
|
|
(16
|
)
|
|
|
(10
|
)
|
|
|
(22
|
)
|
Provision for income taxes
|
|
|
—
|
|
|
|
1
|
|
|
|
—
|
|
|
|
1
|
|
Net loss
|
|
|
(2
|
)%
|
|
|
(17
|
)%
|
|
|
(10
|
)%
|
|
|
(23
|
)%
|
Comparison of Three and Nine Months Ended September 30, 2020 and 2019
Revenue
|
|
Three Months Ended September 30,
|
|
|
Change
|
|
|
|
2020
|
|
|
2019
|
|
|
Amount
|
|
|
%
|
|
|
|
(dollars in thousands)
|
|
Revenue
|
|
$
|
180,691
|
|
|
$
|
94,231
|
|
|
$
|
86,460
|
|
|
|
92
|
%
|
|
|
Nine Months Ended September 30,
|
|
|
Change
|
|
|
|
2020
|
|
|
2019
|
|
|
Amount
|
|
|
%
|
|
|
|
(dollars in thousands)
|
|
Revenue
|
|
$
|
495,413
|
|
|
$
|
262,739
|
|
|
$
|
232,674
|
|
|
|
89
|
%
|
Revenue for the three and nine months ended September 30, 2020 increased by $86.5 million and $232.7 million, respectively, primarily due to an increase in the number of units sold, partially offset by a decrease in average selling price (“ASP”). Revenue for the three months ended September 30, 2020 increased primarily due to increases in revenue from cloud products by $39.3 million, telecommunication products by $29.8 million and legacy products by $17.4 million. The number of units sold increased for the three months ended September 30, 2020 by 725% primarily due to eSilicon products sold. The ASP decreased by 75% due to an increase in the number of units sold of lower ASP eSilicon products. This was partially offset by a decrease in non-product revenue by $3.7 million due to completion of certain license and nonrecurring engineering development agreements.
In the nine months ended September 30, 2020, revenue increased primarily due to increases in revenue from cloud products by $121.6 million, telecommunication products by $74.9 million and legacy products by $36.1 million. The number of units sold increased for the nine months ended September 30, 2020 by 578% primarily due to eSilicon products sold. The ASP decreased by 71% due to an increase in the number of units sold of lower ASP eSilicon products. In addition, non-product revenue increased by $6.3 million due to new license and nonrecurring engineering development agreements.
Cost of Revenue and Gross Profit
|
|
Three Months Ended September 30,
|
|
|
Change
|
|
|
|
2020
|
|
|
2019
|
|
|
Amount
|
|
|
%
|
|
|
|
(dollars in thousands)
|
|
Cost of revenue
|
|
$
|
79,151
|
|
|
$
|
39,749
|
|
|
$
|
39,402
|
|
|
|
99
|
%
|
Gross profit
|
|
$
|
101,540
|
|
|
$
|
54,482
|
|
|
$
|
47,058
|
|
|
|
86
|
%
|
Gross profit as a percentage of revenue
|
|
|
56
|
%
|
|
|
58
|
%
|
|
|
—
|
|
|
|
(2
|
%)
|
|
|
Nine Months Ended September 30,
|
|
|
Change
|
|
|
|
2020
|
|
|
2019
|
|
|
Amount
|
|
|
%
|
|
|
|
(dollars in thousands)
|
|
Cost of revenue
|
|
$
|
227,244
|
|
|
$
|
111,517
|
|
|
$
|
115,727
|
|
|
|
104
|
%
|
Gross profit
|
|
$
|
268,169
|
|
|
$
|
151,222
|
|
|
$
|
116,947
|
|
|
|
77
|
%
|
Gross profit as a percentage of revenue
|
|
|
54
|
%
|
|
|
58
|
%
|
|
|
—
|
|
|
|
(4
|
%)
|
Cost of revenue and gross profit for the three and nine months ended September 30, 2020 increased primarily due to higher revenue as discussed above. Gross profit as a percentage of revenue for both the three and nine months ended September 30, 2020 decreased due mainly to amortization of inventory fair value step-up related to acquired eSilicon inventories of $0.1 million and $4.5 million sold during the three and nine months ended September 30, 2020, respectively, and amortization of acquired intangibles of $6.2 million and $18.0 million for the three and nine months ended September 30, 2020, respectively.
Research and Development
|
|
Three Months Ended September 30,
|
|
|
Change
|
|
|
|
2020
|
|
|
2019
|
|
|
Amount
|
|
|
%
|
|
|
|
(dollars in thousands)
|
|
Research and development
|
|
$
|
66,832
|
|
|
$
|
44,895
|
|
|
$
|
21,937
|
|
|
|
49
|
%
|
|
|
Nine Months Ended September 30,
|
|
|
Change
|
|
|
|
2020
|
|
|
2019
|
|
|
Amount
|
|
|
%
|
|
|
|
(dollars in thousands)
|
|
Research and development
|
|
$
|
198,701
|
|
|
$
|
133,999
|
|
|
$
|
64,702
|
|
|
|
48
|
%
|
Research and development expense for the three and nine months ended September 30, 2020 increased compared to the corresponding 2019 periods primarily due to increase in personnel costs and stock-based compensation of $13.6 million and $42.1 million, respectively, mainly as a result of the eSilicon acquisition, new hires and new equity awards granted to employees. Software tools expense increased by $1.4 million and $7.7 million for the three and nine months ended September 30, 2020, respectively, mainly due to new software license subscriptions and cost of termination of eSilicon contracts. Information technology and allocated expenses increased by $4.1 million and $11.7 million for the three and nine months ended September 30, 2020, respectively, due to the eSilicon acquisition, increased design activities and higher engineering activities. Testing, laboratory supplies, packaging and pre-production engineering mask costs increased by $2.3 million and $3.7 million for the three and nine months ended September 30, 2020, respectively, due to increased research and development activities.
Sales and Marketing
|
|
Three Months Ended September 30,
|
|
|
Change
|
|
|
|
2020
|
|
|
2019
|
|
|
Amount
|
|
|
%
|
|
|
|
(dollars in thousands)
|
|
Sales and marketing
|
|
$
|
15,341
|
|
|
$
|
12,311
|
|
|
$
|
3,030
|
|
|
|
25
|
%
|
|
|
Nine Months Ended September 30,
|
|
|
Change
|
|
|
|
2020
|
|
|
2019
|
|
|
Amount
|
|
|
%
|
|
|
|
(dollars in thousands)
|
|
Sales and marketing
|
|
$
|
45,274
|
|
|
$
|
35,344
|
|
|
$
|
9,930
|
|
|
|
28
|
%
|
Sales and marketing expense for the three and nine months ended September 30, 2020 increased compared to the corresponding 2019 periods primarily due to increase in personnel costs and stock-based compensation by $2.5 million and $8.3 million, respectively, mainly as a result of the eSilicon acquisition, new hires and new equity awards granted to employees. In addition, commission expense increased by $0.8 million and $1.2 million for the three and nine months ended September 30, 2020, respectively, due to higher revenue.
General and Administrative
|
|
Three Months Ended September 30,
|
|
|
Change
|
|
|
|
2020
|
|
|
2019
|
|
|
Amount
|
|
|
%
|
|
|
|
(dollars in thousands)
|
|
General and administrative
|
|
$
|
13,125
|
|
|
$
|
8,165
|
|
|
$
|
4,960
|
|
|
|
61
|
%
|
|
|
Nine Months Ended September 30,
|
|
|
Change
|
|
|
|
2020
|
|
|
2019
|
|
|
Amount
|
|
|
%
|
|
|
|
(dollars in thousands)
|
|
General and administrative
|
|
$
|
38,508
|
|
|
$
|
22,478
|
|
|
$
|
16,030
|
|
|
|
71
|
%
|
General and administrative expenses for the three and nine months ended September 30, 2020 increased compared to the corresponding 2019 periods primarily due to increase in salary and stock-based compensation by $1.6 million and $6.5 million, respectively, mainly as a result of the eSilicon and Arrive acquisitions, new hires and new equity awards granted to employees. Professional service fees increased by $2.1 million and $4.4 million for the three and nine months ended September 30, 2020, respectively, due to the acquisitions. In addition, allocated expenses such as facility, human resources and information technology expenses increased by $0.7 million and $3.2 million for the three and nine months ended September 30, 2020, respectively, due to the acquisition of eSilicon and new building lease for the Company's head office in California.
Provision for Income Tax
|
|
Three Months Ended September 30,
|
|
|
Change
|
|
|
2020
|
|
|
2019
|
|
|
Amount
|
|
%
|
|
|
(dollars in thousands)
|
Provision for income taxes
|
|
$
|
1,188
|
|
|
$
|
619
|
|
|
$
|
569
|
|
|
|
92%
|
|
|
|
Nine Months Ended September 30,
|
|
|
Change
|
|
|
|
2020
|
|
|
2019
|
|
|
Amount
|
|
|
%
|
|
|
|
(dollars in thousands)
|
|
Provision for income taxes
|
|
$
|
1,482
|
|
|
$
|
1,252
|
|
|
$
|
230
|
|
|
|
18
|
%
|
We normally determine our interim provision for income tax using an estimated single annual effective tax rate for all tax jurisdictions. ASC 740 provides that when an entity operates in a jurisdiction that has generated ordinary losses on a year-to-date basis or on the basis of the results anticipated for the full fiscal year and no benefit can be recognized on those losses, a separate effective tax rate should be computed and applied to ordinary income (or loss) in that jurisdiction. We incurred a pretax loss during the three and nine months ended September 30, 2020 and 2019 from our U.S. operations and will not recognize tax benefit of the losses due to the full valuation allowance established against deferred tax assets. Thus, a separate effective tax rate was applied to losses from the U.S. jurisdiction to compute our September 30, 2020 and 2019 interim tax provision.
The income tax expense of $1.2 million and $1.5 million for the three and nine months ended September 30, 2020, respectively, reflects an effective tax rate of (54.2%) and (3.2%), respectively. The effective tax rates for the three and nine months ended September 30, 2020 differed from the statutory rate of 21%, primarily due to the change in valuation allowance, foreign income taxes paid at lower rates, geographic mix in operating results, unrecognized tax benefits, recognition of federal and state research and development credits, windfall tax benefits from stock-based compensation, and GILTI inclusion. The income tax expense for the nine months ended September 30, 2020 included a reversal of certain unrecognized tax benefit as a result of the Internal Revenue Service exam conclusion with a no change report. The reversal of the unrecognized tax benefit had no impact on the income tax provision as a result of the full federal valuation allowance. The income tax expense for the nine months ended September 30, 2020 included an accrual for unrecognized tax benefit for foreign taxes and an income tax benefit for the remeasurement of certain net foreign deferred tax liability based on the renewed tax holiday period in Singapore.
The income tax expense of $0.6 million and $1.3 million for the three and nine months ended September 30, 2019 reflects an effective tax rate of (4.0%) and (2.1%), respectively. The effective tax rates for the three and nine months ended September 30, 2019 differed from the statutory rate of 21% primarily due to the change in valuation allowance, foreign income taxes paid at lower rates, geographic mix in operating results, unrecognized tax benefits, recognition of federal and state research and development credits, and windfall tax benefits from stock-based compensation.
Liquidity and Capital Resources
As of September 30, 2020, we had cash, cash equivalents and investments in marketable securities of $223.0 million. Our primary uses of cash are to fund operating expenses, purchase inventory and acquire property and equipment and business acquisitions. Cash used to fund operating expenses is impacted by the timing of when we pay these expenses, as reflected in the changes in our outstanding accounts payable and accrued expenses. Our primary sources of cash are cash receipts on accounts receivable from our revenue. In 2015, 2016 and 2020, we issued convertible debt, which resulted in an increase in cash, cash equivalents and investments in marketable securities. Aside from the growth in amounts billed to our customers, net cash collections of accounts receivable are impacted by the efficiency of our cash collections process, which can vary from period to period, depending on the payment cycles of our major customers.
The consolidated statement of cash flows for the nine months ended September 30, 2019 has been revised to correct a prior period classification error as discussed in note 1 of the Notes to Unaudited Condensed Consolidated Financial Statements included in this Quarterly Report on Form 10-Q. Accordingly, the discussion below reflects the impact of those revisions.
The following table summarizes our cash flows for the periods indicated:
|
|
Nine Months Ended September 30,
|
|
|
|
2020
|
|
|
2019
|
|
|
|
(in thousands)
|
|
Net cash provided by operating activities
|
|
$
|
110,943
|
|
|
$
|
74,989
|
|
Net cash used in investing activities
|
|
|
(202,471
|
)
|
|
|
(58,243
|
)
|
Net cash used in financing activities
|
|
|
(43,288
|
)
|
|
|
(37,646
|
)
|
Net decrease in cash and cash equivalents
|
|
$
|
(134,816
|
)
|
|
$
|
(20,900
|
)
|
Net Cash Provided by Operating Activities
Net cash provided by operating activities during the nine months ended September 30, 2020 primarily reflected depreciation and amortization of $93.2 million, stock-based compensation expense of $81.3 million, accretion of convertible debt and amortization of issuance expenses of $22.6 million, loss on termination software lease contracts of $3.4 million, loss on early extinguishment of debt of $13.4 million, decrease in prepaid expenses and other assets of $21.2 million, increase in accounts payable of $11.9 million and other liabilities of $2.3 million, partially offset by a net loss of $47.7 million, realized gain on an equity investment of $5.0 million, unrealized gain on equity investments of $1.9 million, increases in accounts receivable of $34.6 million and inventories of $32.3 million, decreases in accrued expenses of $9.9 million, and deferred revenue of $8.0 million. Our prepaid expenses and other current assets decreased due to collection of receivables from eSilicon stockholders to pay eSilicon employees and usage of prepaid expenses. Our accounts receivable increased due to higher revenue. Our accounts payable and inventories increased due to build-up of inventories for future shipments and addition of eSilicon inventories. Accrued expenses decreased due to payment to eSilicon employees as part of the acquisition. Our deferred revenue decreased due to services provided or shipment of products. Other liabilities increased due to estimated liabilities due to sales channel pricing or returns.
Net cash provided by operating activities during the nine months ended September 30, 2019 primarily reflected depreciation and amortization of $73.4 million, stock-based compensation expense of $56.6 million, accretion of convertible debt and amortization of issuance expenses of $21.0 million, decreases in accounts receivable of $4.9 million, prepaid expenses and other assets of $0.8 million, increases in accounts payable of $2.6 million and other liabilities of $1.3 million, partially offset by a net loss of $59.5 million, net unrealized gain on equity investments of $2.1 million, increase in inventories of $23.7 million and decrease in deferred revenue of $1.0 million. Our accounts receivable decreased due to collections. Prepaid expenses and other current assets decreased due to usage. Our inventories and accounts payable increased due to build-up of inventories for future shipments. Our other liabilities increased mainly from estimated liabilities due to sales channel pricing. Our deferred revenue decreased due to services provided.
Net Cash Used in Investing Activities
Net cash used in investing activities during the nine months ended September 30, 2020 primarily consisted of acquisitions of business of $223.7 million, purchases of marketable securities of $41.9 million and equity investments of $6.0 million and purchases of property and equipment of $52.5 million, partially offset by proceeds from maturities and sales of marketable securities of $107.3 million and proceeds from eSilicon investment of $15.0 million.
Net cash used in investing activities during the nine months ended September 30, 2019 primarily consisted of purchases of marketable securities of $216.1 million and equity investment of $3.0 million, purchases of property and equipment of $17.2 million, purchases of intangible assets of $1.1 million, partially offset by proceeds from maturities and sales of marketable securities of $179.2 million.
Net Cash Used in Financing Activities
Net cash used in financing activities during the nine months ended September 30, 2020 primarily consisted of payment for debt retirement and conversion of $410.0 million, minimum tax withholding paid on behalf of employees for net share settlement of $49.2 million, purchase of capped call options of $55.7 million, payment of obligations related to purchase of intangible assets and equipment financing of $31.3 million, partially offset by proceeds from convertible debt, net of cost of $492.7 million, proceeds from the exercise of stock options and ESPP purchases of $10.1 million.
Net cash used in financing activities during the nine months ended September 30, 2019 primarily consisted of minimum tax withholding paid on behalf of employees for net share settlement of $25.7 million and payment of obligations related to purchase of intangible assets and equipment financing of $20.2 million, partially offset by proceeds from the exercise of stock options and ESPP purchases of $8.3 million.
Operating and Capital Expenditure Requirements
Our principal source of liquidity as of September 30, 2020 consisted of $223.0 million of cash, cash equivalents and investments in marketable securities, of which $48.6 million is held by our foreign subsidiaries. Based on our current operating plan, we believe that our existing cash and cash equivalents from operations will be sufficient to finance our operational cash needs through at least the next 12 months. In the future, we expect our operating and capital expenditures to increase as we increase headcount, expand our business activities and grow our end customer base which will result in higher needs for working capital. Our ability to generate cash from operations is also subject to substantial risks described in Part II, Item 1A, Risk Factors. If any of these risks occur, we may be unable to generate or sustain positive cash flow from operating activities. We would then be required to use existing cash and cash equivalents to support our working capital and other cash requirements. If additional funds are required to support our working capital requirements, acquisitions or other purposes, we may seek to raise funds through debt financing or from other sources. If we raise additional funds through the issuance of equity or convertible debt securities, the percentage ownership of our stockholders could be significantly diluted, and these newly-issued securities may have rights, preferences or privileges senior to those of existing stockholders. If we raise additional funds by obtaining loans from third parties, the terms of those financing arrangements may include negative covenants or other restrictions on our business that could impair our operating flexibility, and would also require us to incur interest expense. We can provide no assurance that additional financing will be available at all or, if available, that we would be able to obtain additional financing on terms favorable to us.
We do not plan to repatriate cash balances from foreign subsidiaries to fund our operations in the United States. There may be adverse tax effects upon repatriation of these funds to the United States.
Contractual Payment Obligations
Our outstanding contractual obligations as of December 31, 2019 are included in our Annual Report on Form 10-K for the year ended December 31, 2019. See note 17 of the Notes to Unaudited Condensed Consolidated Financial Statements for information regarding certain contractual obligations as of September 30, 2020.
The Merger Agreement with Marvell provides Marvell and us with certain termination rights and, under certain circumstances specified in the Merger Agreement, we could be required to pay Marvell a termination fee of up to $300.0 million. Also, we recorded acquisition-related costs associated with the pending merger with Marvell primarily for outside legal and external financial advisory fees and expect additional acquisition-related costs will be incurred through the closing of the Mergers.
Off-Balance Sheet Arrangements
As of September 30, 2020, we had no material off-balance sheet arrangements, other than certain noncancelable purchase obligations as discussed in note 17 of the Notes to Unaudited Condensed Consolidated Financial Statements.
Recent Authoritative Accounting Guidance
See note 2 of the Notes to Unaudited Condensed Consolidated Financial Statements for information regarding recently issued accounting pronouncements.